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ABSTRACT: 
Transfer and shedding of a rifampicin-resistant strain of Escherichia coli (RREC) 
among cattle was studied in a research feedlot comprised of 30 pens of 11 or 12 yearling 
steers. On 3 separate occasions, 9, 6 and 6 of the 12 steers in 3 different peripheral pens 
in the lot were orally inoculated with 10 1 1 cells of an unmodified RREC isolate from 
bovine feces. Fecal swabs were performed on all 360 steers in the feedlot immediately 
prior to and at approximately 5-week intervals thereafter. Following inoculation, fecal 
grab samples were collected daily from all 12 pen mates and from the 12 steers in the 
adjacent pen(s) for 2 weeks, then 3 times per week for up to 4 months. In all 3 trials, the 
inoculated steers each shed RREC within 24 h of inoculation. All 12 steers in each 
inoculated pen were positive for RREC within 48 h; all 36 steers shed RREC 
intermittently throughout the three sampling periods. Transfer to 4 steers in an adjacent 
pen was confirmed only during the first trial (3 steers shed once each on day 8, day 26 or 
day 40; the fourth shed on 6 occasions between days 8 and 40). Transfer to non-adjacent 
pens was not detected during any of the 3 trials. All recovered RREC isolates were 
compared to the inocula using LMX agar and fatty acid methyl ester (FAME) analysis. 
Additionally, select recovered isolates were subjected to carbon source utilization tests. 
The three inocula were further subjected to 16S rRNA sequence analysis, minimum 
inhibitory antibiotic concentration profiles and pulsed-field gel electrophoresis and were 
determined to be the same strain. It was observed with the exception of the pen floor, 
that the resistant strain did not move through the animal feedlot environment, as easily or 
pervasively as other studies suggested. The RREC did not persist in the feedlot 
environment beyond the 4-month trial period. Fecal contamination from the pen floor, 
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animal-to-animal contact and the chute system may have facilitated transfer of the 
resistant strain between animals. Animal stress may have facilitated the pen-to-pen 
transfer observed during trial 1, as the inoculation was conducted within 1 week of the 
steers' arrival in the feedlot. 
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1. INTRODUCTION: 
The use of antibiotics in livestock production has been increasingly implicated as 
a possible cause of the emergence of antibiotic resistant bacteria (Davies, 1996; 
Khachatourians, 1998; Levy, 1998). Scientists, government policy makers and the public 
are fearful of the possibility of resistant bacteria being transferred from livestock to 
humans through direct animal contact, indirect environmental contact or by contaminated 
food products. The emergence of antibiotic resistance in potential pathogens, such as 
Escherichia coli, Shigella spp., Salmonella spp. and Staphylococcus aureus, is of 
particular concern because these bacteria may be readily transferred from livestock to 
humans (Novick, 1981). 
Animals are raised for human consumption in North America and most receive 
antibiotics at some point during their lives (Endtz et al., 1991; Helmuth and Protz, 1997; 
Witte 1998; Wegener et al, 1999). Antibiotics are used in cattle production for the 
treatment of disease (therapeutic), prevention of disease (prophylactic) or sometimes to 
increase the production of meat (i.e., to increase weight gain) or milk (sub-therapeutic). 
The sub-therapeutic use of antibiotics is viewed as being economical and the widespread 
adoption of this practice has promoted the intensification of livestock production (Cohen 
and Tauxe, 1986; Gustafson and Bowen, 1997). Large feedlots have found each dollar 
invested in the administration of antibiotics to steers on arrival returns three dollars in 
profit (Gustafson and Bowen, 1997). Broad-spectrum antibiotics that promote growth and 
feed efficiency have also been shown to control endemic diseases in large groups of 
animals. Sub-therapeutic concentrations of antibiotics in feed are high enough to have 
marginal effects on bacterial competition but are low enough to allow bacterial growth 
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and potentially select for resistant bacteria. Of the 22.7 billion kg of broad spectrum 
antibiotics produced each year in the United States, it is estimated that 40% are used in 
the agriculture industry and only 20% are used for therapeutic treatment of animals (Levy 
1998). It has been estimated of the 20 million kg of antibiotics imported and produced 
each year in Canada, half are used in agriculture or aquaculture and only 10% are used 
for therapeutic treatment of animals (Khachatourians, 1998). 
How bacteria spread within the environment is important in understanding the 
incidence and prevalence of antibiotic resistant bacteria and the means by which 
antibiotic resistance may be introduced and maintained within microbial populations 
(Marshall et al, 1990). Further assessment of the risks to human health is imperative. 
Although there are numerous reports of antibiotic resistant bacteria being isolated from 
livestock, the majority of this research focuses on poultry and swine where antibiotic use 
is more prevalent (Center for Veterinary Medicine, 1999). Transmission of antibiotic 
resistant bacteria has not been extensively studied in cattle and never under commercial 
feedlot conditions. 
To examine transfer of an antibiotic resistant bacterium among cattle, it is 
necessary to have a bacterial strain that is readily traceable and detectable within the 
feedlot environment. The strain should also be easily cultured and relatively abundant in 
the gastro-intestinal (GI) tract of cattle. These characteristics will greatly facilitate 
tracking of a marked strain introduced into the heavily populated complex microbial 
community found in the lower GI tract of cattle (Hrubant et al, 1972). Members of the 
family Enterobacteriaceae and enterococci are abundant in cattle feces (Carroll and 
Jasper, 1978). Selective and differential media (e.g., Enterobacteriaceae - Eosin 
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Methylene Blue, MacConkey, LMX; enterococci - Bile Esculin Azide) are readily 
available for the cultivation of these bacteria (Manafi et al, 1991). Furthermore, the 
incidence of antibiotic resistant pathogens from these taxa is of growing concern (Cohen 
and Tauxe, 1986). 
A genetically modified strain is undesirable as regulatory restrictions prevent the 
release of such bacteria into the feedlot environment. Although antibiotic resistant 
bacterial stains can be generated spontaneously by exposure of a large number of cells to 
antibiotics in the laboratory, such strains may exhibit reduced competitiveness and often 
fail to establish within an environment that does not have the selective pressure for the 
resistance trait (Marshall et al, 1990; Williams et al, 1996). Consequently, screening for 
an unique antibiotic resistance marker in bacteria directly isolated from cattle may be the 
approach that is most likely to yield a traceable bacterium capable of establishing within 
feedlot cattle. 
The objectives of this study were to monitor establishment, transfer and 
persistence of an antibiotic resistant bacterium in feedlot cattle. To address these goals, a 
lactose fermenting, rifampicin resistant strain of E. coli (RREC) from cattle feces using 
rifampicin gradient plates was isolated. Cattle in a research feedlot were inoculated with 
this strain and its spread and persistence among animals in the same pen and an adjacent 
pen were documented. The effect of multiple passages of the RREC through cattle hosts 
on transfer and persistence was also examined. 
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2. LITERATURE REVIEW 
2.1 Definition and History of Antibiotics: 
Antibiotics are natural metabolites that kill or inhibit the growth of competing 
bacteria. These compounds are produced by a variety of microorganisms and have 
evolved likely due to inter- and intra-specific competition (Wiener et al, 1998). Their 
discovery is credited to Sir Alexander Fleming of Great Britain, who noted that a 
Penicillium isolate produced a substance that inhibited streptococcal growth. Unaltered 
or chemically modified antibiotics are used by mankind to treat bacterial infections in 
humans and agricultural products. Some bacteria have become antibiotic resistant by 
adapting to the challenges of the antibiotic environment created by either man or 
competing microbes. 
Penicillin was hailed as a miracle drug, killing bacteria that caused many human 
diseases including tuberculosis and pneumonia. Between the mid 1940's and 1970's, 
rapid discovery of new antibiotics made the issue of resistance to older antibiotics of little 
consequence. We are now on the verge of returning to pre-penicillin days when even 
seemingly small infections could turn lethal for the lack of effective drugs. Ironically, 
during a 1945 conference held in New York, Sir Alexander Fleming predicted the demise 
of the new medical antibiotic breakthrough (Staff Reporter, 1945). At a time when all 
antibiotics were administered by injection, he predicted that the public would demand a 
preparation that could be taken by mouth. This in turn would lead to self-medication and 
wrong source treatment with too small of a dose. Fleming stated that bacteria would 
develop resistance rather than be eliminated and that the resistant bacteria would be 
passed on to other individuals. 
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Several years prior to the introduction of penicillin to clinical practices, Abraham 
and Chain described a bacterial enzyme that catalyzed hydrolysis of the /?-lactam ring 
thereby inactivating these antibiotics (Gabay, 1994). Plasmids bearing coding regions for 
antibiotic resistance have been recovered from bacteria stored from the pre-antibiotic era 
and organisms producing P-lactamases have been retrieved from plant specimens stored 
during the 17 t h century (Gabay, 1994; Bergogne-Berezin, 1997). Abraham and Chain 
predicted that these enzymes would interfere with the potential therapeutic use of 
penicillin (Gabay, 1994). 
2.1.1 Agricultural Use: 
During the 1940's, commercial producers of penicillin and vitamin B12 began 
using corn as a fermentation substrate. Fermentation residues were evaluated as poultry 
and livestock feeds (Fisher, 1994). Favorable effects on livestock performance were 
noted, including an improvement in growth and feed efficiency as well as a reduction in 
health problems such as post-weaning diarrhea. It was soon discovered that these 
beneficial effects were linked to antibiotics in the fermentation residues. This led to the 
common practice of including sub-therapeutic levels of antibiotics in animal feed 
(Cheeke, 1999). 
Most animals raised for human consumption in Canada and the United States 
receive antibiotics at some point during their lives (Endtz et al, 1991; Helmuth and 
Protz, 1997; Witte, 1998). Antibiotics are used in cattle production for the treatment of 
disease (therapeutic), prevention of disease (prophylactic) or to increase productivity 
such as weight gain or milk production (sub-therapeutic). The mechanisms of growth 
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promotion by antibiotics are speculated to be linked to affects on intestinal micro flora. 
Visek (1978) proposed five hypotheses to explain growth promotion: i) suppression of 
sub-clinical infections, ii) reduction of microbial toxins, iii) reduction of nutrient 
destruction by microflora, iv) enhancement of nutrient absorption due to a thinning of 
intestinal walls and v) increased energy for growth rather than immune system response 
to gut micro flora. Although antibiotics have been used in feeds since the 1950's, their 
effectiveness as growth promotants has not diminished with time and there remain large 
economic incentives for their use (Schell, 1984; Levy, 1992; Gustafson and Bowen; 
1997; Dunlop et al, 1998; Khachatourians, 1998). 
Bacterial diseases common in cattle are listed in Table 2.1. Therapeutic treatment 
of these diseases is the most common reason for antibiotic administration. Table 2.2 lists 
the bacterial targets of antibiotics commonly used for beef and dairy cattle. If label 
recommendations are followed, this type of chemotherapy shortens the duration of 
administration and usually reduces the amount of antibiotics used. Consequently, the risk 
of bacteria developing resistance is minimized. 
Broad-spectrum antibiotics that promote growth and feed efficiency have also 
been shown to control endemic diseases in intensively raised livestock. Prophylactic 
treatment of an entire herd or flock when only a few animals appear sick is considered 
both efficient and effective in maintaining herd health. The use of antibiotics to control 
bovine respiratory disease is a common practice in North America. Operators of large 
feedlots have found that each dollar invested in the administration of antibiotics to steers 
on arrival to the feedlot, returns three dollars in profit (Gustafson and Bowen, 1997). 
Economic advantages have made the use of antibiotics practical and promoted 
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Table 2.1: Common diseases in beef and dairy cattle treated with antibiotics and 
antimicrobial agents (McAllister et al, 2001). 
Condition 
Common 
Bovine Respiratory Disease 
(Pneumonia) 
Enteric Disease 
(Diarrhea) 
Mastitis 
Foot Rot 
Metritis 
(Uterine Infection) 
Ocular 
(Pink Eye) 
Less Common 
Lumpy Jaw 
Listeriosis 
Anaplasmosis 
Tetanus (Black Leg) 
Wooden Tongue 
Causative Bacteria 
Pasteurella haemolytica 
Pasteurella multocida 
Haemophilus somnus 
Mycoplasma bovis 
Escherichia coli 
Clostridium perfringens 
Salmonella spp. 
Staphylococcus aureus 
Streptococcus agalactiae 
Klebsiella/ E. coli/ Enterobacter 
Pseudomonas spp. 
Actinomyces pyrogenes 
Fusobacterium necrophorum 
Bacteroides spp. 
Actinomyces pyrogenes 
Fusobacterium necrophorum 
Bacteroides spp. 
Moraxella bovis 
Actinomyces bovis 
Listeria spp. 
Anaplasma marginale 
Clostridium spp. 
Actinobacillus lignieresii 
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Table 2.2: Examples of common antibiotics and antimicrobial agents administered to 
cattle (McAllister et al, 2001). 
Antibiotic Family (Source) Trade Names Target-action 
Aminoglycosides {Micromonospora spp., Streptomyces spp.) 
Gentamicin Gentamicin 
Cephalosporins (Cephalosporium acremonium) 
Ceftiofur sodium Excenel 
Cephapirin Meticure Sus. 
Ionophores {Streptomyces spp.) 
Monesin Rumensin 
Lasalocid Bovatec 
Salinomycin Posistac 
Macrolides {Streptomyces spp.) 
Tilmicosine Micotil 
Erythromycin Erythro-36 
Tylosin Tylan 
Penicillins {Penicillium spp.) 
Penicillin G Formula 17900 
Primarily Gram negative, 
Inhibit protein synthesis 
Broad spectrum activity, 
Inhibits cell wall synthesis 
Primarily Gram positive 
Interferes with ion transport 
Primarily Gram positive, 
Inhibits peptide bond 
formation 
Cloxacillin 
Primarily Gram positive, 
Propen LA, Albacillin Inhibits cell wall synthesis 
Orbenin Quick Release, 
Dry Clox 
Ampicillin Polyflex sterile 
Tetracyclines {Streptomyces spp.) 
Tetracycline HC1 
Chlorotetracycline 
Oxytetracycline HC1 
Others 
Florfenicol 
Novobiocin 
Pilimycin HC1 
Aureomycin 
Oxy LP, Tetraject LP 
LA 300, Liquamycine 
Nuflor 
Albadry 
Pirsue 
Broad spectrum, inhibits 
protein synthesis 
Broad spectrum; inhibits 
bacterial protein synthesis 
Inhibits protein and nucleic 
acid synthesis 
Primarily Gram positive; 
inhibits protein synthesis 
Trimethoprim/ 
Sulfadoxine 
Trivetrin, Borgal 
Sulfamethazine, 
AS-700 
Broad spectrum inhibiting 
thymidine synthesis 
Broad spectrum inhibiting 
folic acid synthesis 
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intensification of livestock and poultry production (Cohen and Tauxe, 1986; Gustafson 
and Bowen, 1997). 
Antibiotic feed additives benefit both livestock and consumers. Healthy animals 
are stronger and grow more efficiently. They incur lower veterinary bills, require less 
feed and are brought to market earlier. This allows the same amount of meat to be 
produced by fewer animals, requiring less feed and water and producing less excrement. 
Thus, it also helps preserve the environment. 
Another benefit associated with the use of antibiotics in food-producing animals 
is a potential decrease in pathogen shedding (Ebner and Mathew, 2000). Animals 
carrying increased amounts of pathogens at the time of slaughter may present an 
increased risk for food contamination and human disease. Consequently, it is possible 
that the use of antibiotics in livestock production dramatically decreases the incidence of 
zoonotic disease (e.g., Salmonella). 
2.2 Development of Antibiotic Resistance in Bacteria: 
Antibiotic resistance exists in microbes found in numerous environments. Natural 
environments that have never been exposed to manufactured antibiotics have 
microorganisms that exhibit antibiotic resistance (Hart, 1998). This may be a result of 
organisms producing metabolites as a means of competing for limited resources. 
Resistance has developed in the producing organisms as a defense against their own 
synthesized antibiotics. The competing microbe may have also evolved antibiotic 
resistance as protection in response to these competitive attacks. 
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2.2.1 Naturally Occurring Antibiotic Resistance: 
In the soil environment, antibiotics are synthesized by saprophytic organisms such 
as streptomyces and actinomycetes. These organisms represent 10 - 50% of all 
culturable bacteria found in soil (Bergogne-Berezin, 1997). A gram of dry soil can 
contain up to 10 6 culturable colony-forming units (CFU). Plasmids are known to be a 
major vehicle for the natural transfer of antibiotic resistant genes and are frequent, 
particularly in actinomycetes like streptomyces. As a result, the soil and natural 
environment constitute a huge reservoir of antibiotic resistance genes (Wiener et al, 
1998). 
It has been generally accepted that antibiotic resistance has a fitness cost to the 
producing bacteria (Lenski, 1997). A resistant bacterium is considered disadvantaged 
when compared to a susceptible bacterium unless they are in the presence of an antibiotic 
(Hartley and Richmond, 1975). 
There are a number of studies that have described the low prevalence of antibiotic 
resistant bacteria in populations of humans or animals that have never been exposed to 
antibiotics (Hartley and Richmond, 1975; Hughes and Datta, 1983; Rolland et al, 1985). 
The most current example of this examines antibiotic resistant Enterobacteriaceae 
cultured from the feces of bank voles (Clethrionomys glareolus) and wood mice 
{Apodemus sylvaticus) (Hart, 1998). These animals were not exposed to antibiotics or 
near areas of agriculture where antibiotic therapy may have been a factor. Of all the 
coliforms cultured during this study, 14-16% were resistant to tetracycline, 90% were 
resistant to ampicillin and amoxycillin and 100%) were resistant to chloramphenicol. 
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All enterococci exhibit inherent low-level resistance to aminoglycosides such as 
gentamicin, kanamycin and streptomycin with minimum inhibitory concentrations 
(MICs) of 2-16ug/ml (Rice et al, 1995). Levy (1992) argues this low prevalence of 
resistant bacteria is a result of long-term exposure to antibiotics entering the environment 
from human or agricultural treatment sources. Others have argued it may reflect a 
continuing selective pressure from low-level antibiotics naturally occurring in the 
environment (Hartley and Richmond, 1975; Hart, 1998). This selective pressure is acting 
upon genotypes that may have arisen by one of two processes, spontaneous mutation or 
lateral gene transfer. 
2.2.2 Spontaneous Mutation: 
Evolutionary forces include spontaneous mutation and lateral gene transfer. All 
living organisms acquire mutations because of normal cellular processes and exposure to 
mutagens within the environment. The opportunities for spontaneous mutation resulting 
in a unique genetic trait such as antibiotic resistance, even occurring at low rates (10" n 
per generation), are far greater for prokaryotes than they are with any other life form 
(Davies, 1994). Unlike organisms that are more complex, the generation time of a 
bacterium such as Escherichia coli may be as short as 20 minutes. Furthermore, bacteria 
exist in astronomical abundance (4-6 x 10 3 0 cells) on the earth (Whitman et al, 1998). 
There are more bacteria in 1 ml of rumen fluid in a cow (1 x 10 1 0) than there are people 
inhabiting the earth (McAllister et al, 2000). 
Spontaneous mutation is considered the least significant in the development of 
antibiotic resistance. By example, the mutation rates for the acquisition of resistance to 
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streptomycin by Enterobacteriaceae such as E. coli or Salmonella typhimurium occur at 
frequencies of 10"9 or less per bacterial generation (Davies, 1994). Lateral gene transfer 
is considered more relevant when assessing the risk of antibiotic resistance transfer 
between bacteria. 
2.2.3 Lateral Gene Transfer: 
Lateral gene transfer allows resistance that has evolved many generations ago 
through spontaneous mutation, to be shared with other bacteria of different species or 
even genera (Courvalin, 1996). Genetic exchange among bacteria occurs by one of three 
distinct mechanisms: conjugation, transformation or transduction. These processes are 
often mediated by a number of mobile genetic elements including plasmids, transposons, 
bacteriophage and gene cassettes (Recchia and Hall, 1997; Cleaver and Wickstrom, 
2000). 
2.2.3.1 Conjugation: 
Conjugation allows for the transfer of blocks of heterologous DNA between 
donor and recipient cells. Conjugative transfer can occur between Gram-negative and/or 
Gram-positive bacteria (Coffey et al, 1998; Khachatourians, 1998). Conjugative transfer 
of plasmids and transposons has been suggested as the major factor contributing to the 
rapid rise in antibiotic resistant pathogens (Waters, 1999). This subject has been 
extensively reviewed (Davies, 1997; Coffey et al, 1998; Hawkey, 1998; Khachatourians, 
1998; Davidson, 1999; Mazel and Davies, 1999; Waters, 1999; de la Cruz and Davies, 
2000). 
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2.2.3.2 Transformation: 
Free DNA exists in the environment because of bacterial cell lysis. During 
transformation, (under natural conditions) competent cells take up naked DNA and may 
incorporate it into their genome. Little is known about the proportion of bacteria of a 
given community that are naturally transformable. 
Few studies have been published dealing with transformation in the field (Graham 
and Istock, 1978; Bechet et al, 1993; Paul et al, 1993; Barbosa et al, 1999; Haack and 
Andrews, 2000; Demaneche et al, 2001; Nwosu, 2001). The degree of horizontal gene 
transfer was studied in bacteria under ideal noncompetitive conditions in the lab and in 
bacteria living in the natural environmental. Conditions conducive to transformation are 
far less frequent under in vivo conditions than during in vitro conditions and are therefore 
considered a minimal risk in the transfer of antibiotic resistance (Courvalin, 1996; Droge 
et al, 1999). An example of laboratory versus field conditions was conducted in a fresh 
water habitat (Williams et al, 1996). Transformation rates under "field" conditions 
differed significantly from those done under parallel laboratory microcosm conditions. 
Replicated field studies showed a high degree of variability in transformation 
frequencies. In the laboratory, treatments were minimized to single parameter influences. 
In the field, the bacteria are submitted to numerous changing conditions that cannot be 
replicated in the lab. Under environmental conditions the transformation rate was far 
less, if it occurred at all, and changed each time the rate of gene transfer was assessed. 
Environmental experiments are difficult to replicate given all of the confounding factors 
involved. In the lab, replication is achievable but this does not accurately represent field 
conditions. The study conducted by Williams and co-workers suggests that lab-based 
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estimates of transformation may substantially overestimate the extent to which this 
process occurs in natural environments. 
Broad host range plasmids and transposons conferring antibiotic resistance have 
been successfully introduced into rumen bacteria in vitro (Wallace, 1994). Sulfonamides 
and trimethoprim have effectively been used for many decades in human and animal 
health treatments. Resistant to both of the antibiotics has spread extensively and rapidly. 
It is believed that this increased resistance is due mainly to lateral gene transfer of 
plasmids or transposons (Skold, 2001). 
2.2.3.3 Transduction: 
DNA transfer occurring through transduction is mediated by bacteriophages 
through faulty packaging of donor DNA and transfer of these sequences to a recipient cell 
(Khachatourians, 1998; Droge et al, 1999). Transduction is limited to closely related 
species because of the high degree of specificity of the absorption step during 
bacteriophage invasion (Courvalin, 1996). The potential for gene transfer via 
transduction in nature has been inferred from studies that report on high concentrations of 
bacteria and phages in terrestrial habitats as well as aquatic habitats (Wommack et al, 
1992; Paul et al, 1993). 
2.3 Mechanisms of Antibiotic Resistance: 
In order for an antibiotic to be effective at restricting growth or killing a bacterial 
population, it must meet three requirements: a biochemical target, a mechanism for 
transport or uptake and absence of enzymes that could inactivate or modify the antibiotic 
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in a manner that renders it ineffective (Khachatourians, 1998). A change in any of these 
conditions could render a sensitive bacterium resistant to one or several drugs. Bacteria 
have developed at least nine antibiotic resistance mechanisms (Table 2.3). The following 
examples of antibiotic resistance mechanisms are described in order to give the reader an 
appreciation for the diversity of the subject. Mechanisms of antibiotic resistance have 
been extensively reviewed in the scientific literature (Gutmann et al, 1990; Dever and 
Dermody, 1991; Davies, 1997; Hawkey, 1998; Khachatourians, 1998; Mazel and Davies, 
1999; Olsen, 1999). 
2.3.1 Reduced Uptake into the Cell: 
Gram-positive bacteria are surrounded by a thick peptidoglycan cell wall. This 
structure however offers little resistance to the diffusion of small antibiotic molecules that 
carry a charge such as fluoroquinolones (Nikaido, 1994). In contrast, Gram-negative 
bacteria have an additional outer membrane that surrounds a thin peptidoglycan layer and 
acts as a barrier to antibiotics. This outer membrane is more complex than the plasma 
membrane and includes lipopolysaccharides (carbohydrates that are bonded to lipids). In 
order for nutrients to diffuse across this barrier, cells such as E. coli have developed 
membrane channels called porins. Porins act as an entry point for some antibiotics like 
fluoroquinolones (Nikaido, 1994). By reducing the uptake of the drug into the target cell 
through the modification of the cell membrane and the utilization of efflux pumps, a cell 
can become resistant (Nikaido, 1994; Hooper, 2001). 
15 
Table 2.3: Molecular mechanisms of antibiotic resistance in bacteria (modified from 
Hayes and Wolf 1990). 
Mechanism Antibiotic 
Reduced uptake into cell 
Active efflux from cell 
Modification of target to eliminate or reduce 
binding of antibiotic 
Inactivation of antibiotic by enzymatic modification: 
Hydrolysis 
Derivatization 
Sequestration of antibiotic by protein binding 
Metabolism bypass of inhibited reaction 
Binding of specific immunity protein to 
antibiotic 
Overproduction of antibiotic target 
Chloramphenicol 
Tetracycline 
P-lactams 
Erythromycin 
Lincomycin 
Rifampicin 
P-lactams 
Erythromycin 
Aminoglycosides 
Chloramphenicols 
Fosfomycin 
Lincomycin 
P-lactams 
Fusidic acid 
Sulfonamides 
Trimethoprim 
Bleomycin 
Sulfonamides 
Trimethoprim 
Biofilms Multiple Drug Resistance 
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23.2 Efflux Pumps: 
Efflux mechanisms have become broadly recognized as major resistance 
components to many classes of antibiotics. Some efflux pumps selectively extrude 
specific antibiotics while others referred to as multi-drug resistance (MDR) pumps, expel 
a variety of structurally diverse compounds with differing antibacterial modes of action. 
Multiple antibiotic resistance in bacteria was at first thought to be caused 
exclusively by the combination of several resistance genes, each coding for resistance to 
a single drug. More recently, it has become clear that such phenotypes are often achieved 
by the activity of drug efflux pumps (Nikaido, 1994). Some of these efflux pumps exhibit 
an extremely wide specificity covering practically all antibiotics, chemotherapeutic 
agents, detergents, dyes, and other inhibitors. These efflux pumps work with exceptional 
efficiency in Gram-negative bacteria through their synergistic interaction with the outer 
membrane barrier (Nikaido, 1994). Efflux pumps developed inii . coli, Staphylococcus 
aureus and Streptococcus pneumoniae have been studied extensively (Levy, 1992; 
Hinrichs et al, 1994; Aminov et al, 2001; Hooper, 2001). 
2.3.3 Modification of Target: 
Rifampicin binds to the p-subunit of RNA polymerase, inhibiting DNA 
transcription. By modifying the targeted enzyme without disrupting its function the 
bacterium is able to continue with DNA replication and counteract the inhibiting effects 
of rifampicin. Rifampicin resistance is expressed as an altered target enzyme through 
numerous insertions, deletions or amino acid substitutions within the target enzyme 
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(Fukuda and Nagasawa-Fuj imori, 1983). Most of the seventeen reported alterations 
occur within a highly conserved region (residue 507 to 534) of the p-subunit of RNA 
polymerase (Spratt, 1994; Ingham and Furneaux; 2000). 
In some clinical Gram-positive isolates, enzymatic modification of rRNA is the 
most prevalent mechanism of resistance to macrolides. Erythromycin and other 
macrolides inhibit bacterial growth by blocking protein synthesis through binding to the 
50S subunit of the bacterial ribosomal subunit. RNA methylase adds a methyl group to 
the 50S subunit, thereby preventing the binding of erythromycin. The methylated subunit 
however, remains functional and normal protein synthesis continues in the erythromycin-
resistant cells (Davies, 1994). 
2.3.4 Enzymatic Modification: 
Hydrolytic inactivation by P-lactamases is one mechanism of resistance to p-
lactam antibiotics. The cleavage of a bond in the p-lactam ring renders antibiotics like 
penicillin and ampicillin inactive (Davies, 1994). A single base change in the gene for P-
lactamase can change the substrate specificity of the enzyme P-lactamase demonstrating 
how easily resistance to P-lactams can evolve (Davies, 1994). 
The aminoglycoside phosphotransferases (APHs) are responsible for the bacterial 
inactivation of many clinically useful aminoglycoside antibiotics (Thompson et al, 1998; 
Suter et al, 1997). By transferring a phosphate group from ATP on to an antibiotic such 
as neomycin, the cell renders the antibiotic ineffective (Thompson et al, 1996). In a 
similar manner, molecules such as acetyl or adenyl groups may be attached to 
aminoglycoside antibiotics and result in antibiotic inactivation (Daigle et al, 1999). 
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2.3.5 Antibiotic Sequestration: 
Coumarins such as coumermycin bind to the P-subunit of DNA gyrase. This 
enzyme is essential for maintaining DNA supercoiling and is critical to DNA replication. 
Cellular production of a gene product that binds to the coumermycin as it enters the cell, 
allows DNA replication to continue in the resistant cell (Del Castilla et al, 1991). 
2.3.6 Metabolic Bypass: 
Synthesis of antibiotic-insensitive bacterial targets is the primary mechanism for 
resistance against trimethoprim, and sulfonamides (Dever and Demody, 1991). 
Resistance by E. coli to sulfanomides (sulfa drugs) and trimethoprim is acquired by the 
acquisition of a gene encoding a new enzyme that is insensitive to these antibiotics. 
These drugs inhibit different reactions in the bacterial metabolic pathway that produce 
tetrahydrofolic acid, an essential cofactor in the synthesis of nucleic acids (Spratt, 1994). 
The altered enzymes are fully functional and allow the metabolic pathway to continue 
producing tetrahydrofolic acid uninhibited. 
2.3.7 Biofilms: 
Biofilms represent complex communities with functional heterogeneity allowing a 
protected mode of growth in a challenging environment (Costerton et al, 1999). It has 
been demonstrated that members of biofilms are less susceptible than their planktonic 
counterparts to antibiotic therapies (Bardouniotis et al, 2001). Sessile cell barriers 
prevent bacteriostatic antibiotics from penetrating the full depth of the biofilm thereby 
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protecting the embedded active cells. Polymeric substances that make up the matrix of 
the biofilm restrict antibiotic diffusion. A variety of cell metabolic states such as those 
found in biofilms are best suited to fend off metabolic attacks by an antibiotic (Brown et 
al, 1988; Costerton et al, 1999; De Kievit et al, 2001; Stewart and Costerton, 2001). 
2.4 Factors Contributing to the Development of Resistance: 
Resistance poses not only a financial burden to our health system with direct costs 
estimated at $100 million per year in the United States, but also can result in a traumatic 
loss of human life (Khachatourians, 1998). At the turn of the century tuberculosis, 
pneumonia and diarrhea were the leading causes of illness accounting for almost 30% of 
human deaths (Cohen, 1997). Over the next few decades the frequency of deaths related 
to these infectious diseases declined because of societal changes, including improved 
hygiene and sanitation, better housing, food safety and water quality. Advances in 
antibiotic therapy are also credited for improved human health (Cohen, 1997). For many 
diseases, antibiotics were key in both the treatment of the infection and in restricting 
transmission of the disease among the general public. 
Antibiotics have been incorporated into human and agricultural health systems. 
The debate as to which of the two has contributed to the emergence of the antibiotic 
resistant bacterial "super bug" has been the topic of scientific and non-scientific reviews 
for many years. 
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2.4.1 Human Misuse and Overuse of Antibiotics: 
As personal incomes have increased, so too have demands for better health care. 
Easy access to antibiotics and promises of cures to illness have increased the number of 
prescriptions and inappropriate prescriptions for antibiotics (Schaffner et al, 1983; 
McCraig and Hughes, 1995; Schwartz et al, 1997). Cohen (1997) suggests that at the 
same time we are making huge strides in technology with respect to disease cures, a 
larger complacency towards infectious diseases has developed (Figure 2.1). 
The complacency towards infectious diseases has led to the emergence of 
antibiotic resistance by either influencing antibiotic use and/or increasing the 
transmission of the infectious agents. Factors such as i) changes in human demographics 
and behavior, ii) changes in technology and industry, iii) economic development and land 
use, iv) international commerce and travel, v) bacterial adaptation and change and vi) the 
breakdown of public health measures have all played a part in the emergence of antibiotic 
resistant bacteria (Cohen, 1997). For many pathogenic bacteria, combinations of these 
different factors have resulted in increased frequencies of resistance. 
An increase in two income and single parent families has been correlated with 
increased daycare usage for children (Cohen, 1997). This gives many opportunities for 
the transmission of resistant bacteria between small children. Changing patterns of 
immigration needs to also be considered (Cohen, 1997). Today's populations are more 
interactive and diverse than ever before. We meet and interact with individuals from all 
over the world every day. This means we increase the likelihood of transmission of 
antibiotic resistant bacteria beyond our local communities. 
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Figure 2.1: Emergence of clinically important antibiotic resistant human 
pathogens from 1950 to present. Question marks represent those strains of 
bacteria that we have yet to identify as resistant, (modified from Cohen, 1992). 
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New medical technologies such as organ transplants and management for diseases 
such as AIDS have been particularly important in the emergence of antibiotic resistance 
(Cohen, 1997). Along with the advances that prolong life, are those that increase hospital 
stays of individuals that are immune compromised as a result of surgeries and various 
diseases. These individuals are not only susceptible to infections but also act as 
reservoirs for resistant bacteria within the hospital or clinical institutions. 
Greater populations and extended land use have increased person-to-person 
contact and the potential transmission of resistant bacteria. Increased populations also 
lead to stresses on water and sanitation systems (Cohen, 1997; Williams and Heymann, 
1998). 
More than 50 million unnecessary antibiotic prescriptions are written each year 
for patients of hospitals according to estimates by the Center for Disease Control and 
Prevention in the United States (Center for Veterinary Medicine, 1999) (Figure 2.2). 
Respiratory infections account for more than 75% of antibiotic drug prescriptions 
annually in the United States (Schwartz et al, 1997). Although some patients suffering 
from cough or bronchitis may benefit, the majority of the patients receiving antibiotic 
prescriptions for these illnesses do not (Orr et al, 1993; Gonzales and Sande, 1995). The 
main reason cited for the inappropriate prescribing during a 1993 study by physicians 
was related to unrealistic patient expectations and insufficient time for physicians to 
explain why an antibiotic prescription was inappropriate (Vinson and Lutz, 1993). 
Educating both the physicians and the public to the implications of antibiotic misuse and 
overuse is essential to the reduction of emerging antibiotic resistance. 
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Figure 2.2: Estimated unnecessary antibiotic prescriptions prescribed by clinical 
physicians per year in the United States compared to the total number of 
prescriptions written for those conditions (Center for Veterinary Medicine, 1999). 
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The development of antibiotic resistant populations of bacteria continues every 
time a patient takes a specific antibiotic for an appropriate bacterial infection. The drug 
may kill most of the infecting bacteria but some bacteria may survive by mutating or 
acquiring resistance genes from other resistant bacteria through lateral gene transfer. 
Patients receiving antibiotics often experience an increase in resistant gut micro-flora 
(Cohen, 1992; Perchere, 1994; Weinstein, 2001). Antibiotics lead to a shift in the 
competitive balance resulting in a proliferation of resistant bacteria due to their advantage 
under the antibiotic selective pressure (Levy, 1992). The surviving cells can multiply 
quickly as new antibiotic-resistant strains. As a result, the patient's next infection may 
not respond to the antibiotic therapy used during the previous treatment and this new 
resistant strain may be transferred to other patients in the community. Hospitals, nursing 
homes and daycares pose the greatest risks for this profile of resistance transmission 
(Cohen, 1997). 
2.4.2 Role of Animal Production in Antibiotic Resistance: 
While numbers have not been established with certainty, it is estimated that of the 
22.7 billion kg of antibiotics produced in the United States during 1998, over 40% were 
used for animal husbandry and crop purposes and that only 20% of those were used for 
therapeutic treatment of disease in animals (Levy, 1998). The remaining 80% of 
antibiotics employed in livestock production were used for prophylactic or growth 
promotion purposes. 
Many studies have been cited with respect to the isolation of antibiotic resistant 
bacteria from animals. The focus has been on poultry and swine where the majority of 
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antibiotics are used (Tables 2.4 and 2.5). Five conclusions arise from a survey of the 
literature in these two tables. The studies involving poultry indicate that the use of 
antibiotics in food-producing animals is generally not associated with an increase in 
pathogen shedding. Similarly, with the exception of penicillin, antibiotics had no impact 
on pathogen shedding in swine. However, the scope of these studies is rather narrow, as 
most studies have focused on Salmonella spp. with other potential pathogens essentially 
being ignored. Finally, although most of the studies indicate that pathogen loads are not 
increased in the animals as a result of antibiotic use, they suggest that antibiotics may 
contribute to the prevalence of antibiotic resistance bacteria. This association is made by 
the authors regardless of having scientific data to support this conclusion. The following 
are further examples of studies that contribute to the hypothesis that antibiotic use in 
agriculture leads to antibiotic resistance without sufficient scientific data to support this 
claim. 
Levy (1976b) studied resistant patterns in E. coli isolated from the feces of farm 
personnel after tetracycline was introduced into chicken feed. An increase in tetracycline 
resistant E. coli in the chickens was observed within one week of administration of the 
tetracycline supplemented feed and was undetectable soon after removal of the antibiotic 
from the animal feed. Similar increases were observed for tetracycline resistant E. coli 
cultured from the feces of farm personnel working with the chickens within 5 to 6 months 
after the start of the experiment. However, more tetracycline resistant E. coli were 
simultaneously cultured from people in the community that had never been knowingly 
exposed to the antibiotic during the study. This suggests that other factors may have been 
involved in the resistant bacteria colonizing the human gut and minimizes the suggested 
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Table 2.4: Effect of antibiotics on bacteria during challenge studies involving calves, swine and chickens. Symbols are interpreted as follows: (~) approximately the same, (<) less than 
Animal Concentration of Result (excretion of test animal vs. 
Species Antibiotic Tested Antibiotic in Feed Outcome Species Analyzed controls) Publication 
Calves oxytetracycline 2) 101.01 g/ton S. typhimurium <(quantity) 
~ prevalence and 
rate of decrease of 
shedding) 
Evangelistic a/., (1975) 
Calves oxytetracycline and neomycin 94.4 g/ton S. typhimurium < (quantity, 
prevalence), ~ (rate 
of decrease of 
shedding) 
Girarde/a/., (1976) 
Pigs lincomycin llOmg/kg S. typhimurium ~ DeGreeter et al, (1976) 
Pigs 1) ceftiofur 
sodium oxytetracycline 
2) apramycin/oxytetracycline 
3) carbadox/oxytetracycline 
1) Unknown 
100 g/ton 
2) 150, 100 g/ton 
3) 50, 100 g/ton 
S. typhimurium 
2)< 
3)~ 
Ebner and Mathews (2000) 
Pigs oxytetracycline 150 g/ton S. typhimurium ~ Evangelisti et al, (1975) 
Pigs oxytetracycline and neomycin 150 g/ton each S. typhimurium 1)< Girard et al, (1976) 
Pigs 1) chlortetracycline 1) 220.5 g/tonne S. typhimurium 1)< Gutzmann et al, (1976) 
2) chlortetracycline, sulfamethazine, 110.2, 110.2, 2)~ 
penicillin G 55.1 g/ton 
Pigs efrotomycin 16 mg/kg S. typhimurium ~ Jacks et al, (1988) 
Pigs neomycin, oxytetracycline, 
nitrofurazone 
110, 110-440 g/ton 
100mg/l 
S. typhimurium Wilcock and Olander (1978) 
Pigs chlortetracycline 110 mg/kg S. typhimurium 
(resistant and 
sensitive strains) 
> (resistant strain), 
< (sensitive strain) 
Williams et al, (1978) 
Chickens virginiamycin 25 g/ton & typhimurium ~ Abou Youssef et al, (1982) 
Chickens avoparcin 2.5-100 mg/kg S. typhimurium, S. pullorum, S. cholerae 
S. dublin, S. arizonae, E.coli, streptococi 
and obligate aerobes, lactobacilli 
> {Salmonella spp., E.coli 
at lOOmg/kg), 
< (streptococci and obligate 
aerobes at lOOmg/kg), 
~ (lactobacilli) 
Barrow et al, fl984) 
Chickens nosiheptide 20 g/ton S. typhimurium and E. coli ~ {S. typhimurium and E. coli) Benazet and Cartier, (1980) 
Chickens 1) flavophospholipol 1)9 mg/kg S. enteritidis, Campylobacter jejuni, < {Salmonella ) , ~ {Clostridium Bolder et al, (1999) 
Clostridium perfringens and Campylobacter) 
Table 2.4: Continued 
Animal Concentration of Result (excretion of test animal vs. 
Species Antibiotic Tested Antibiotic in Feed Outcome Species Analyzed controls) Publication 
Chickens oxytetracycline 200 g/ton S. typhimurium < Evangelisti et al, (1975) 
Chickens oxytetracycline and neomycin 200 g/ton each S. typhimurium < Girard et al, (1976) 
Chickens avoparcin with and 10 mg/kg, with S. typhimurium Gustafson et al, (1982) 
without monensin 100 mg/kg 
Chickens aviamycin with and 2.5 and 10 ppm Salmonella kedougou ~ Hinton (1988) 
without monensin lOOppm 
Chickens 1) avoparcin 10 mg/kg Salmonella infantis 1)< Holmberg, (1984) 
2) monensin 90 mg/kg 2)< 
3) avoparcin and 10 mg/kg and 3)> 
monensin 90 mg/kg 
Chickens chlortetracycline 200 g/ton S. enteritidis, S. infantis, S. typhimurium < Jarolmen et al, (1976) 
Chickens enrofloxacin 10 mg/kg S. enteritidis < Seo etal, (2000) 
Chickens 1) virginiamycin, Bacitracin 10 and 100 mg/kg S. typhimurium l ) ~ o r > Smith and Tucker (1975a) 
flavomycin, tylosin 
2) nitrovin 10 and 100 mg/kg 2)> 
3) sulphaquinoloxaline 100 and 500 mg/kg 3)< 
Chickens 1) neomycin, ampicillin 100 and 500 mg/kg S. typhimurium l ) < o r ~ Smith and Tucker (1975b) 
spectinomycin, polymixin 
streptomycin, furazolidone, 
chloramphenicol, 
oxytetracycline 
2) trimethoprim, 20-100 mg/kg 2)< 
sulphadiazine 100-500 mg/kg 
Chickens 1) lincomycin 10 mg/kg 1)> Smith and Tucker (1978) 
avoparcin 100 mg/kg 
2) ampolium, menosin 125, 100 mg/kg 2 ) ~ 
dimetridazole, arsenilic acid, 150,250 mg/kg 
nitro-hydroxyphenylarsonate 446 mg/kg 
Chickens 1) avoparcin 10 mg/kg S. typhimurium (nalidixic-acid resistant 
and sensitive), S. heidelberg, 
S. oranienburg, S. infantis, S. senftenberg 
1)> Smith and Tucker (1980) 
2) Bacitracin 10 mg/kg 2 )~ 
3) sodium arsenilate 250 mg/kg 3)< 
Table 2.5: Effect of antibiotics on bacteria during observational studies involving poultry, swine and steers. Symbols are interpreted as follows: (~) 
approximately the same, (<) less than and (>) greater than. Multiple studies in single papers are represented in numerical format (i.e. 1), 2) or 3); modified 
from Center for Veterinary Medicine, 1999). 
Animal 
Species Antibiotic Tested 
Concentration of 
Antibiotic in Feed Outcome Species Analyzed 
Result (excretion of test 
animal vs. controls) Publication 
Steers monensin 
Pigs 1) penicillin 
2) streptomycin 
3) penicillin and 
streptomycin combo. 
Pigs 1) penicillin 
2) streptomycin 
3) penicillin and 
streptomycin combo. 
Pigs chloratetracycline, 
oleandomycin, 
sulphamethazine, 
procaine penicillin, 
oxytetracycline 
1) penicillin 
33 mg/kg 
1)227 mg/lOOlbs 
2) 250 mg/lOOlbs 
3) 227 and 250 mg/lOOlbs 
1) 227 mg/100 lbs 
2) 250 mg/lOOlbs 
3)227and250mg/1001bs 
10-100 mg/lb 
2mg/lb 
50 mg/lb 
25 mg/lb 
8 mg/lb 
1) 10 g/ton 
Total anaerobic bacteria 
Total bacteria, enterobacteriacae 
Coliform bacteria, Proteus, 
Shigella, Staphylococcus 
Bordetella bronchisptica, 
Hemophilus suis, Pasturella 
multicoda, Streptococcus 
equisililis, and Mycoplasma spp. 
Streptococci, lactobacilli and 
conforms 
2) Aurofac 2) 3 lb/ton 
Chickens 1) monensin sodium 100 mg/kg 
2) avoparcin, notrivon, 10-20 mg.kg 
virginiamycin 
Chickens Bacitracin, erythromycin, 50 g/ton 
penicillin, streptomycin 
or oxytetracycline 
Turkeys avoparcin, virginiamycin 20 ppm 
Salmonella spp. 
E. coli, Klebsiella pneumoniae, 
Proteus mirabilis, 
Pseudomonas spp. 
Salmonella spp. 
> 
1)> 
2 ) ~ 
3 )~ 
1) (coliform), ~ (others) 
2) ~ (all organisms) 
3) >(coliform, Proteus) 
~ (Shigellaa, 
Staphylococcus) 
~ o r < 
Dawson and Boling (1983) 
Bridges et al, (1952) 
Bridges et al, (1953) 
Woodsy al, (1972) 
1)<(Streptococci), Fullered/., (1960) 
~ (lactobacilli, coliforms) 
2)~ 
1)~ Hinton etal, (1986) 
2) No conclusion could 
be made. 
Mamber and Kaltz (1985) 
Smith and Green (1980) 
link between the farm personnel and feeding of antibiotics to chickens. Current studies 
show prevalent tetracycline resistance exists naturally in the environment and in gut flora 
of wild animals that have never been exposed to tetracycline (Hart, 1998). Specific 
numbers of cultured tetracycline resistant E. coli are not presented in this study. As a 
result, there is insufficient evidence to support the presented conclusion that there is 
direct evidence for potential transfer of antibiotic resistant bacteria (and in particular 
tetracycline resistant E. coli) between chickens and humans. 
Perhaps the greatest health threat is the lateral gene transfer of antibiotic resistant 
determinants from livestock to people and their subsequent colonization of the intestinal 
tract. A second study conducted by Levy (1976a) provides potential evidence for transfer 
of plasmids between bacteria that reside in livestock and those that reside in humans. 
This study involved cloaca! inoculation of chickens with a transformed tetracycline-
resistant strain of E. coli. Chickens were fed tetracycline as a feed supplement to 
enhance bacterial colonization of the gut with tetracycline-resistant bacteria. Transfer of 
the resistance plasmid was detected in fecal micro-flora from the chickens and in fecal 
samples collected from the handlers of the chickens. Because the strain was unmarked, it 
is unknown if the plasmid transferred from bacteria in the animals to bacteria in the 
humans or vice versa. There is the possibility that the resistant E. coli were selected for 
in the human gut as a result of the exposure of handlers to antibiotic dust during animal 
feeding. This was not taken into consideration during this study (Levy, 1976a). 
Water could serve as a reservoir for the transfer of resistant bacteria to humans. 
This may be accomplished through consumption of contaminated recreation water, 
untreated drinking water or cultivated crops that have been watered with contaminated 
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irrigation water (Beuchat, 1999; Venkitanarayanan et al, 1999). Contamination of water 
sources may be accomplished by downward movement of fecal material through the soil 
profile into the groundwater or fecal material flowing with surface water runoff from 
livestock production facilities. Improper handling of contaminated post-harvest produce, 
may serve as an antibiotic-resistance contamination source (Jawson et al, 1982; Crane et 
al, 1983; Thornley and Bos, 1985; Moore, 1991; Hooda et al, 2000). 
It is generally agreed that the use of antibiotics inevitably results in some degree 
of bacterial resistance. The question remains, however, if the resistant bacteria in cattle 
pose a significant health risk to humans. Many of the antibiotics that could potentially 
lead to antibiotic resistant bacterial pathogens in humans have not been approved for use 
in North American cattle (McAllister et al, 2001). 
2.5 Transfer of Antibiotic Resistant Bacteria: 
The uses of antibiotics in clinical medicine and in livestock production represent 
potential point sources for the development of antibiotic resistant bacteria (Figure 2.3). 
Bacteria move through the environment by a variety of routes and their presence 
ultimately has consequences to human health (Khachatourians, 1998) (Table 2.6). 
Perhaps the primary concern with regard to the emergence of resistance should 
focus on those classes of antibiotics that are used in both animal and human medicine 
including those that are used in livestock production and that cause cross-resistance to 
antibiotics used by humans. Human clinical treatments include aminoglycosides such as 
gentamicin and streptomycin to treat serious bacterial infections. Ampicillin, amoxacillin 
and penicillin G are used to treat a variety of human infections including typhoid fever, 
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Figure 2.3: The agricultural use of antibiotics in animal feed can result in the selection and transmission of antibiotic resistant bacteria. 
These bacteria move through the environment by a variety of routes, and their presence ultimately has consequences to human health, 
(modified from Khachatourians, 1998). 
Table 2.6: Transferring bacterial pathogens in livestock and humans including illnesses 
caused in humans by each bacterial strain (modified from Novick, 1981). 
Species 
Escherichia coli 
Enteric disease-producing E. coli 
Shigella sp. 
Salmonella sp. 
Pseudomonas sp. 
Klebsiella-Aerogenes group 
Yersinia enterocolitica 
Yersinia psuedotuberculosis 
Brucella sp. 
Pasteurella multocida 
Listeria 
Erysipelothrix 
Bacillus anthracis 
Mycobacteria 
Leptospira 
Staphylocccus aureus 
Streptococcus agalactiae 
Clostridium perfringes 
Chlamydia psittacii 
Mycoplasma sp. 
Illness Caused in Humans 
Intestinal Infection 
Intestinal Infection 
Intestinal Infection 
Food Poisoning 
Meningitis 
Urinary Tract Infections 
Food Poisoning 
Food Poisoning 
Brucellosis 
Wound Infections 
May be a vertebrate pathogen 
Eyrsipeloid 
Malig. Pustule Pneumonia 
Tuberculosis 
Weil Disease 
Cellulitis 
Neonatal Meningitis 
Gas Gangrene 
Orithosis 
Bronchitis 
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chlamydia, peptic ulcer disease and Lyme disease. Tetracyclines are also used to treat 
various human diseases including shigellosis and food poisoning. Sulfonamides and 
trimethoprim combinations are used to treat urinary infections. These same antibiotics 
are commonly used in animal husbandry (Table 2.2). 
Possible risk to human health comes from the movement of antibiotic-resistance 
genes from bacteria in food to bacteria that cause human disease such as Salmonella spp., 
Enterococcus spp., E. coli, Streptococcus spp., and Campylobacter spp. These bacterial 
strains killed many people during the pre-antibiotic era and even though they are 
susceptible to some antibiotics, they have exhibited resistance to multiple antibiotics. 
The following is a brief summary of antibiotic resistance in these pathogens and their 
transfer between animals and humans. 
2.5.1 Methicillin resistant Staphylococcus aureus: 
Methicillin is a last resort antibiotic treatment for S. aureus infections. S. aureus 
is the number one cause of infection in hospital patients in the United States. It is a 
common source of infection in individuals recovering from burn and surgical wound 
(Roman et al, 1997). In Canada, the first methicillin-resistant S. aureus (MRSA) was 
reported in 1981 and since then MRSA account for about 5% of all S. aureus infections 
reported (Health Canada, 1997). Glycopeptides such as vancomycin are the last resort 
control of MRSA infections in humans. To date, antibiotic use in cattle has not been 
linked to the development of resistant staphylococci that are of primary concern in human 
health (McAllister et al, 2000). In May 1993, however, an outbreak of MRSA was 
identified in western Canada (Roman et al, 1997). Investigation indicated that the strain 
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had entered the country by a patient who had been hospitalized in Punjab, India. 
Incidents of illness followed the movement of the index case through Canada and further 
through those he was in contact with prior to identifying his infection. The freedom with 
which individuals travel not only locally but globally further emphasizes the risks 
antibiotic-resistant bacteria pose. 
2.5.2 Vancomycin-resistant Enterococci (VRE): 
Increasing reliance on vancomycin as a last resort treatment may have led to the 
emergence of vancomycin-resistant enterococci (VRE). Until 1989, such resistance had 
not been reported in American hospitals. By 1993, more than 10% of the hospital-
acquired enterococci infections reported to the Center for Disease Control were 
vancomycin resistant (Levy 1998). In some groups of hospital patients, VRE is on the 
rise and now represents 20% to 40% of all enterococci related infections in United States 
hospitals (Khachatourians, 1998). 
Vancomycin-resistant enterococci are of increasing interest due to their clinical 
implications. In Europe, the rate of human fecal carriage of VRE isolates in the community 
is greater than those tested in the United States. Until recently, avoparcin, a glycopeptide 
that promotes cross-resistance to vancomycin (Stobberingh et al, 1999), was commonly used 
in the Netherlands. Two separate studies confirmed Pulse Field Gel Electrophoresis (PFGE) 
patterns of VRE isolated from animals and the human caregivers of those animals were 
different suggesting the transfer of the resistance bacteria between animals and humans was 
nonexistent or occurred at very low frequency (van den Braak et al, 1998; Stobberingh et al, 
1999). Perhaps it may be hypothesized from these studies that selective pressure for the 
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human VRE isolate is located within practices in human medicine as opposed to agricultural 
production practices. Incidences of VRE in the United States support this hypothesis. 
Although serious outbreaks have occurred in Europe, VRE-associated infections have not 
increased at the same rate or to the same extent as they have in the United States where 
glycopeptide antibiotics have not been approved for use in animal husbandry (Wegener et al, 
1999; Rice, 2001). 
2.5.3 Campylobacter: 
Reports from the scientific and public health communities, both domestically and 
internationally, have identified concerns about the relationship between the approval of 
fluoroquinolones for therapeutic use in animals reared for food and the development of 
fluoroquinolone resistance in Campylobacter. The use of these drugs in livestock 
production in the Netherlands, the United Kingdom and Spain slightly preceded increases 
in fluoroquinolone-resistant Campylobacter isolates from humans. In the United States, 
ciprofioxacin-resistant Campylobacter were recently isolated from 20% of domestic retail 
chicken products sampled (Smith et al, 1999). Campylobacter spp. isolated during a 
seven-year period in the Netherlands from poultry products and human stool samples 
showed patterns of increasing resistance that could be correlated to increased 
fluoroquinolone use (Endtz et al, 1991). This study concluded that increases were both 
in human and animal isolates, but failed to identify the origin of the resistant bacteria. 
A recent study in Vancouver, Canada revealed a natural resistance to the 
fluoroquinolone ciprofloxacin in bacterial populations isolated in city-area soil (Waters 
and Davies, 1997). There was a high degree of variability in the fluoroquinolone target 
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DNA gyrase. This meant that even without selective pressure these bacteria showed 
fluoroquinolone resistance suggesting that Campylobacter resistance to fluoroquinolones 
may be innate. The implications of this study may be that blaming the poultry industry 
for fluoroquinolone resistance is unjustified. 
2.5.4 Escherichia coli: 
E. coli is a normal inhabitant of many animal and human intestinal tracts. 
Normally E. coli serves a useful function in the body by suppressing the growth of 
harmful bacteria and by synthesizing appreciable amounts of vitamins (Khachatourians, 
1998). In recent years, E. coli 0157:H7 has come to the forefront of public and 
government concern. E. coli 0157:H7 is an emerging cause of food borne illness with an 
estimated 73,000 cases of infection and 611 deaths occurring in the United States each 
year (Center for Veterinary Medicine, 1999). Most persons recover without antibiotics or 
other specific treatment in 5-10 day. There is no evidence that antibiotics reduce the 
duration of the disease, and it is thought that treatment with some antibiotics may cause 
kidney complications. 
Intestinal E. coli can be a reservoir for transferable antibiotic resistance plasmids 
(Khachatourians, 1998). Transfer of nalidixic acid or rifampicin resistant E. coli strains 
between different animals species has been studied under non-selective conditions 
(Marshall et al, 1990). Primary screens for the resistant E. coli strains were constructed 
by transformation of nalidixic acid resistant or rifampicin resistant E. coli with a traceable 
multi-resistance plasmid. Using antibiotic selection, the study followed the transfer of 
the resistance plasmids and E. coli isolates from of each of a heifer and a bull inoculated 
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with each strain, through the environment to other animal hosts within the barn 
environment including humans, pigs, mice, chickens and flies. No antibiotics were given 
to any of the animals. Approximately 9 x 10 1 0 of the combined nalidixic acid and 
rifampicin resistant E. coli cells were orally administered on three occasions over a 4-day 
period to the heifer and bull. Despite high frequencies of plasmid transfer between 
different gut bacteria during laboratory experiments, very low frequencies of plasmid 
transfer occurred in the inoculated bovine gut community and no transfer of the plasmids 
was detected in the other animal's (flies, mice, chickens or pigs) intestinal micro-flora. 
Antibiotic resistant E. coli were recovered up to 4 months post inoculation but the 
quantity of transformed E. coli cells shed from the cattle decreased quickly following 
inoculation. The results of this study suggest that transfer of the antibiotic resistant 
bacteria amongst different animal species occurred under non-selective conditions, the 
transfer of an antibiotic resistant plasmid was not detected despite gut colonization in the 
cattle for up to 4 months post inoculation. Competitive exclusion (and thus the necessity 
of high inoculation for isolate establishment) could be considered as a reason for non-
transfer. 
2.5.5 Salmonella-. 
In 1997, salmonellosis accounted for 41,901 reported cases of illness in the 
United States (Center for Veterinary Medicine, 1999). It is estimated that this is a 
fraction of the 2 to 4 million cases of salmonellosis occurring annually in the United 
States (Center for Veterinary Medicine, 1999). Salmonella spp. are commonly isolated 
from livestock, especially poultry and swine. Environmental sources of the organism 
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include water, soil, insects, factory work surfaces, animal feces, raw meats, raw poultry 
and raw seafood. 
Salmonella enterica (MR-DT104) was studied over a 15-year period by Davies 
and co-workers (1999). Increases in the isolate resistance patterns were noted in both 
cattle and humans during this period. Isolates susceptible to all drugs tested were more 
common in humans than in cattle. Although antibiotic-resistant S. enterica (MR-DT104) 
were found in both cattle and humans so too were sensitive strains of S. enterica (MR-
DT104). Davies and co-workers (1999) suggested that local antibiotic selection pressure 
may have played a role in the dissemination of the resistant isolates from cattle to 
humans. The study also noted that early in the global dissemination of MR-DT104, the 
bacteria were isolated from wildlife that had little or no exposure to antibiotics. Davies 
and co-workers (1999) suggested that factors other than antibiotic selective pressure are 
necessary for the spreading of resistant organisms. 
2.6 The Politics of Antibiotic Resistance: 
During the course of this literature review, many (>280) peer-reviewed articles 
that addressed aspects of antibiotic resistance were reviewed. Of the 130+ articles cited 
in this paper, >75% were review articles. Only four articles (Evangelisti et al, 1975; 
Girard et al, 1976; Dawson and Boling, 1983; Marshall et al, 1990) deal with cattle and 
of these only one (Marshall et al, 1990) deals with the transfer of resistant strains. 
Evidence for the risk of antibiotic resistant bacteria directly related to cattle and 
agricultural use is lacking. Despite this lack of scientific data, numerous political and 
public inquires have proposed that agricultural use of antibiotics is a major contributor to 
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antibiotic resistance in the environment. Several governments around the world have 
responded to real or perceived factors contributing to antibiotic resistance. 
2.6.1 The Swann Committee: 
In 1965, a large outbreak of Salmonella food poisoning occurred in Britain 
(Fisher, 1994). Although past outbreaks were quickly controlled with the use of 
antibiotics, patients during this outbreak failed to respond to treatment resulting in six 
deaths. In 1969, the government appointed Swann committee was established. The 
committee was made up of microbiologists and physicians charged with finding an 
explanation for the failure of treatment during the 1969 incident. Sub-therapeutic use of 
antibiotics in animals for extended periods and hence the selection for resistant bacteria 
was cited as placing humans at risk of infection by antibiotic-resistant bacteria. The 
committee recommended banning routine use of antibiotics in animals and banning all 
use of antibiotics that were concurrently used in human therapy. Use of other antibiotics 
in feed could continue but would require a veterinarian's prescription. The 
recommendations were accepted in 1970 in Britain and soon after other European 
countries adopted the same recommendations. In April 1977, the Federal Drug 
Administration of the United States lobbied to adopt the Swann Committee 
recommendations, but failed due to the protests and lobbying from the agricultural 
community (Marshall, 1980). 
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2.6.2 Europe 's Response to Antibiotic Resistance: 
In the United Kingdom, public and government organizations paid little attention 
to antibiotic resistance during the period between the 1969 report of the Swann 
Committee and the emergence of MRSA and antibiotic-resistant tuberculosis in humans. 
With the emergence of MRSA, it was decided that a new committee should be appointed 
to consider the role of science and technology in addressing antibiotic resistance (Seventh 
Report to the House of Lords, 1998). The inquiry was described as an alarming 
experience for committee members convincing them that antibiotic resistance was a 
major threat to public health. 
The Seventh Report to the House of Lords (1998) made recommendations for the 
prudent use of antibiotics in human medicine and for the use of antibiotics in animals. 
Antibiotic growth promoters such as virginiamycin should be phased out, preferably by 
voluntary agreement between the professionals and the industries concerned. It was 
recommended that a code of practice be introduced to monitor the use fluoroquinolones, 
reported to be excessively prescribed by veterinarians. Further recommendations 
included an improved surveillance system to track the emergence of antibiotic resistance 
and the establishment of a single multidisciplinary Government committee with the 
mandate of overseeing all aspects of antibiotic use. 
Infection control, surveillance, new drug development, vaccines, antiviral drugs 
and the support of the World Health Organization (WHO) Division of Emerging Diseases 
were also covered in the House of Lords Report (1998). By the committee members' 
own admissions, many of the conclusions drawn during the study were assumptions but 
they continued to put recommendations forth despite the lack of scientific data. In some 
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cases researchers warned of the complete ban of antibiotics in agriculture could have 
undesirable consequences such as an increase in potential human pathogens within 
livestock populations (Hinton et al, 1984). 
In the August 9, 1999 issue of Cattle Buyer's Weekly it was mentioned that the 
EU is moving toward a total ban on the use of antibiotics in animal feed, despite 
warnings that a ban would make European meat more expensive not only due to 
increased production costs but also due to import restrictions. Regardless of the potential 
economic costs, the EU has been steadily moving towards a complete ban on the sub­
therapeutic administration of antibiotics. It previously allowed the use of eight antibiotics 
but now has banned four of them and the remaining four antibiotics will be phased out, 
starting in 2001. The reasoning behind the ban is that antibiotics are being used to prevent 
disease, rather than curing it. Authorities believe this constitutes misuse of antibiotics and 
has advocated that their use in livestock production be discontinued. EU officials admit 
they lack clear scientific evidence to link the use of antibiotics to the growing antibiotic 
resistance in humans, but they say that the risk of potential antibiotic resistance to human 
health outweighs any economic impact of a ban. 
2.6.3 The United States' Response to Antibiotic Resistance: 
In 1988 the Institute of Medicine (IOM) of the United States reviewed all of the 
information available on risk to human health associated with the use of antibiotics for 
treatment of animals used for food production and their inclusion in livestock feed to 
promote growth. The committee found a considerable amount of indirect evidence 
implicating both sub-therapeutic and therapeutic use of antibiotics as a potential human 
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health hazard. The committee strongly recommended further study of the issue (Center 
for Veterinary Medicine, 1999). Since 1988 the Food and Drug Administration (FDA) 
Center for Veterinary Medicine (CVM) has approved new antibiotics for use in food-
producing animals on a prescription only basis. This prescription only policy is based on 
the need to assure the proper use of antibiotics through pre-diagnosis and correct 
treatment of disease to minimize animal suffering and to avoid drug residues in food. 
Antibiotics for use in animals must meet FDA's standards for safety, efficacy and quality 
to be approved in the United States (Center for Veterinary Medicine, 1999). 
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During the first session of the 107 Congress May 9 , 2001, an act cited as 
"Antibiotic Resistance Prevention Act of 2001" was presented. The act requested 
funding for top priority action items in response to the public health action plan to 
combat antimicrobial resistance. Highlights of the report included a national antibiotic 
resistance surveillance plan that included the monitoring of antibiotic use in the United 
States. Prevention and control of resistance would be addressed as well as research and 
product development. Committee co-chairs included the Task Force on Antibiotic 
Resistance (established 1999), the CDC and FDA. Members included Agencies for 
Healthcare Research and Quality, Health Resources and Services Administration, 
Healthcare and Finance Administration, Environmental Protection, Departments of 
Agriculture, Defense and Veteran's Affairs. In general the committee promoted 
comprehensive strategies that use multiple interventions for appropriate drug use and 
infection control. The committee was equally committed to intervention in human and 
agricultural environments. As a result of their broad-spectrum approach, the 
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recommendations of the committee seem more conservative when compared to the 
European response of totally banning antibiotic use in animal husbandry applications. 
2.6.4 Canada's Response to Antibiotic Resistance: 
The Laboratory Centre for Disease Control (LCDC) in collaboration with the 
Canadian Infectious Disease Society (CIDS) organized a conference May 1997, entitled 
"Controlling Antimicrobial Resistance: An Integrated Action Plan for Canadians". 
Approximately 200 people from health, agriculture, aquaculture, and pharmaceutical 
industries, the public and media participated in the conference. The objectives of the 
conference included reporting current factors contributing to antibiotic resistance, 
creating an action plan to be implemented in public and professional education regarding 
the issue of resistance, implementation of a national surveillance program and 
development of a plan for anticipating and responding to obstacles that could prevent the 
realization of the action plan. 
To address some of the industry and consumer concerns regarding antibiotic 
resistance, a medical research team from the University of Calgary in June 1999 began a 
two-year study to look for links between the use of antibiotics in cattle and the rise of 
antibiotic resistant bacteria in people. The Canada Alberta Beef Industry Development 
Fund has committed $976, 462 for this research. The pork producers also have expressed 
interest in pursuing similar studies. 
The National Information Program on Antibiotics (NIP A) is a coalition of eight 
health organizations concerned with the issue of appropriate use of antibiotics in Canada. 
This group focuses on public and physician understanding of the issue of antibiotic 
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resistance. NIP A has been active since 1996 to raise awareness in Canada about the need 
for responsible use of antibiotics. During the past five years, NIPA has developed a wide 
range of educational materials to encourage dialogue between health care professionals 
and patients, including the coalition's website (www.antibiotics-info.org); the NIPA 
Antibiotics Tool Kit which contains antibiotics compliance pads, non-prescription pads 
and information pamphlets; and an "Antibiotics: Use Them Wisely" poster for use in 
pharmacies and physicians' offices. 
January 2001, NIPA took the opportunity to unveil its Canada-wide consumer 
advertising campaign about the importance of prescribing antibiotics appropriately and 
using them wisely. The program expected to reach more than 3.5 million Canadians 
through an extensive print campaign in popular Rogers Media magazines like Chatelaine 
(English and French), Today's Parent, Healthy Woman, Enfant Quebec and Sante 
Femme. The campaign is aimed at not only creating greater awareness of the issue but 
also motivating significant change in Canadians' attitudes toward antibiotics. 
2.7 The Take Home Message: 
The present review includes references addressing the issue of antibiotic 
resistance, its development, mechanisms and transmission between animals and animals 
and humans. Most studies directly challenging animals involved poultry, a few involve 
swine and even fewer involve cattle. With respect to experimental design, all fall into 
one of two categories: those that involved the artificial inoculation of animals and those 
that monitored transmission of resistance under laboratory conditions. The most common 
bacteria used in these studies were Salmonella spp. and the transmission of plasmids 
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involved laboratory competent strains of E. coli. The results of the inoculum studies 
suggested resistance could be mediated through animal husbandry but were based on 
laboratory results of plasmid transfer. 
Several European countries have banned sub-therapeutic antibiotic use in 
livestock production. North American restriction of antibiotic use in livestock production 
is also gaining political popularity despite the lack of evidence that antibiotic resistance is 
a direct result of antibiotic use in animal husbandry. 
The message established by this review is the lack of current relevant studies to 
assess the degree to which antibiotic use in beef cattle production poses a threat to human 
health. Further studies monitoring establishment and transmission such as the study 
currently being conducted by the University of Calgary are imperative in allowing us to 
make informed and prudent choices regarding antibiotic usage in livestock production 
systems. 
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3. MATERIALS AND METHODS: 
All animals employed in these studies were cared for under the guideline of the 
Canadian Council of Animal Care (1993). 
3.1 Isolation of Inoculum (RREC I): 
Fecal samples (50-100 g) were collected from 10 yearling steers housed at the 
Lethbridge Research Centre feedlot using plastic sample bags and digital palpation (fecal 
grab samples). Samples were then transferred to the lab, weighed and lg sub-samples 
were combined with 24 ml sterile double distilled water (diF^O) and mixed in a model 
400 stomacher (Seward; Mississauga, ON) on high speed for 2 min to create a slurry. 
Duplicate aliquots (250 ul) were spread on antibiotic gradient plates ( 0 - 1 0 0 ug/ml; 
Bryson and Szbalski, 1952; Gentile et al, 1992) prepared with MacConkey (Difco, 
Beckton Dickinson, Sparks, MD) or Bile Esculin Azide (BEA) agar (Sigma Aldrich 
Canada Ltd., Oakville, ON) and rifampicin (Rm; Sigma), streptomycin (Sigma), 
gentamicin (Sigma) or nalidixic acid (Sigma). In addition, 100 jlxI of the fecal slurry from 
each animal were spread on MacConkey or BEA agar plates to ensure that the antibiotics 
were the selective criterion rather than the MacConkey or BEA media. 
The gradient plates were examined for distinct lactose fermenting (MacConkey 
plates) or distinct black (BEA plates) colonies that were growing on the plates in the area 
of high antibiotic concentration following incubation (24 h at 37°C). The level of 
resistance of these colonies was estimated and recorded. A distinct rifampicin resistant 
(Rm r) colony (15 ug Rm/ml) was harvested from a MacConkey + Rm agar gradient plate 
and streaked for purity on Trypticase Soy agar (TSA; Difco) and incubated (24 h at 
37°C). The Rm r isolate, named Rifampicin Resistant E. coli (RREC I), was assessed for 
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growth on Eosin Methylene Blue agar (EMB; Difco) and tryptophanase activity in 
peptone water (Holt, 1994). Stocks of RREC I (1 ml) were created in triplicate using 
brain heart infusion (BHI; BDH Inc., Toronto, ON) broth and 15% glycerol and stored at 
-80°C for future use. 
3.2 Stability of RREC I: 
The RREC I cells were grown in 5 ml of TSB (Difco) in a shaking incubator 
(Model Inova 4080 New Brunswick Scientific Company Inc.; Edison New Jersey) at 
39°C and the resulting culture was transferred, using an inoculation loop, into 5 ml of 
fresh TSB every 12 h for 7 d (>200 generations). Each 12 h culture was enumerated by 
the spread plate technique. Serial dilutions prepared with 50 mM sodium phosphate 
buffer (pH 7.0) dilution blanks (9 ml) were spread in triplicate on MacConkey agar and 
MacConkey agar containing 50 u.g Rm/ml (MacConkey + Rm agar) and incubated 
overnight at 39°C. 
3.3 Preliminary Cattle Study (Small Scale): 
A preliminary study was performed to assess the ability of RREC I to colonize 
and persist in cattle. Prior to inoculation with RREC I, 15 yearling steers from the 
Lethbridge Research Centre feedlot were screened for background lactose fermenting 
Rm r CFU to determine if background Rm r isolates would be of concern for tracking our 
marked strain. Fecal samples were placed in plastic bags and transported back to the lab 
for processing within 1 h of collection. Fecal material (10 g wet weight) was combined 
with 90 ml sterile sodium phosphate buffer and stomached for 2 minutes on high speed to 
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create a slurry. The resulting suspension was spread in triplicate on MacConkey + Rm, 
incubated at 39°C overnight and examined for lactose fermenting Rm r colonies. 
Following screening for lactose fermenting Rm r CFU, fistulated yearling Jersey 
steers (n = 3) were inoculated with RREC I to determine if the isolate could be 
established and recovered from inoculated animals. The inoculum for each animal was 
prepared by growing RREC I cells in 100 ml of TSB in a shaking incubator at 39°C. 
Cells were harvested by centrifugation and re-suspended in 50 ml sodium phosphate 
buffer. Animals were inoculated directly into the rumen through rumen cannulae. 
Rumen samples were collected at 0,12 and 24 h post inoculation (p.i.) and 100 ul 
aliquots were plated in triplicate on MacConkey + Rm agar and incubated overnight at 
39°C. Fecal grab samples were also collected from each animal every 12 h (0 h - 96 h) 
and then daily for 2 weeks p.i. Samples were enumerated for the presence of Rm r lactose 
fermenting CFU/g feces (wet weight) as previously described. 
3.4 Feedlot Cattle Study: 
3.4.1 Feedlot Environment and Animal Background: 
3.4.1.1 Sample Collection: 
Prior to the arrival of experimental animals at the Lethbridge Research Centre 
feedlot, background environmental samples were collected from feed troughs, fences, soil 
samples from the pen floor and water bowls. Fences were swabbed (1-1.5 m above the 
pen floor) in two locations, near the water trough and above the feed bin for each pen 
using a sterile swab. Duplicate heavy feed particles and dust samples (10-100 g) were 
collected from each feed bunk using a plastic sample bag. Pen floor samples (10 - 50 g) 
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were collected using plastic sample bags from two areas, near the water trough and near 
the feed bunk from all thirty pens to be used during the trial. Duplicate water samples 
(500 ml) were collected from each of the water troughs (n = 15). Samples were collected 
from the edge of the bowl after stirring contents to ensure sediment was collected along 
with the water sample. 
Within 24 h of arrival at the Lethbridge Research Centre, yearling steers (n = 360 
weighing 350 - 400 kg) were weighed and fecal swabs were collected from each animal. 
Sterile transport swabs (Starplex Scientific; Etobicoke, ON) were inserted into the rectum 
(5-7cm) of each animal and immediately placed in modified Amies media prior to being 
transported to the lab where they were examined for the presence of Rm r bacteria. All 
pens (13 .54mx 19.7 m) were open to the environment with windbreaks installed 
between pens restricting animal-to-animal contact except at water bowls that were 
located at the fence line and shared between 2 adjacent pens. Feed bunks were located at 
the roadway face of each pen (Figure 3.1). Animals were bedded using barley straw. 
Standard pen maintenance and feeding protocols were followed throughout the trial 
periods. 
3.4.1.2 Enumeration and Isolation of Rm r Cells: 
Feed bunk samples (10 g) were combined with 90 ml of sterile sodium phosphate 
buffer and mixed for 2 min using a stomacher set on high speed to create a slurry. Fence 
swabs were removed from the transport media and streaked across the agar plates. Pen 
floor materials were mixed by hand until homogeneous and 10 g was placed into 90 ml of 
sterile sodium phosphate buffer. Samples were stomached for 2 minutes on high to 
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Figure 3.1: Schematic drawing of the research feedlot at the Lethbridge Research Centre. 
Yearling steers (n = 360) were housed in groups of 12 in pens 17-46. Animal sampling 
was conducted in the sheltered barn. Animals involved in the first inoculation resided in 
pens 24 (inoculated steers and pen mates) and 23 (adjacent pen steers). Animals involved 
in the second inoculation were housed in pen 17 (adjacent pen 18) and animals involved 
in the third inoculation were housed in pen 21 (adjacent pen 22). 
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create a slurry. Water samples were agitated in the collection jars prior to filtration. 
Samples (100 ml) were filtered through a 0.2 um membrane filter (Gelman Sciences, Pall 
Corporation; Ann Arbor, MI) using a vacuum filtration system and filters were plated. 
The cotton tips were removed from the rectal swabs and placed in 1.5 ml microtubes 
containing 500 ul sterile sodium phosphate buffer and mixed with a vortex mixer (Model 
Genie 2 Fisher Vortex; Bohemia, NY). 
All materials processed above were plated (100 ul) or streaked on MacConkey + 
Rm agar plates. Random samples were selected from each environmental group and 
plated on MacConkey agar to ensure rifampicin was the selective criterion. The plates 
were incubated for 24 h at 39°C and then examined for lactose fermenting (bright pink) 
colonies. Fence and rectal swabs were scored qualitatively for growth (positive or 
negative) while CFU/g or CFU/ml were determined for feed trough and pen floor 
samples or water bowl samples, respectively. 
Cells from isolated lactose fermenting colonies from MacConkey + Rm agar were 
streaked onto TSA and LMX agar and incubated 24 h at 39°C. Stock cultures were 
created by suspending cells from isolated colonies on the TSA plates in 1 ml BHI broth 
containing 15% glycerol. Stock cultures were placed in 1.5 ml cryotubes and stored at -
80°C for future use. In addition, cells used to prepare stock cultures were subjected to 
fatty acid methyl ester (FAME) analysis and compared to the inoculated strain. 
3.4.2 Inoculation of Cattle with RREC I: 
RREC I cells from a glycerol stock were grown overnight in 10 ml TSB 
containing 50 \ig Rm/ml in a shaking incubator at 39°C. Cells from the resulting culture 
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(10 ul loop) were used to inoculate 18 (1 L) flasks containing TSB (250 ml). Cultures 
were incubated at 39°C overnight. The following day, the cultures were enumerated by 
the spread plate technique. Serial dilutions were plated on both MacConkey agar and 
MacConkey + Rm agar to determine the number of Rm r CFU. 
Nine of twelve yearling steers in pen 24 were orally inoculated with 5 x 10 1 2 
RREC I cells followed by a water wash (500 ml). Animals were subsequently sampled 
over a four-month period. Prior to feeding, steers from pen 23 were run through the 
feedlot chute system followed by cattle from pen 24. The order of the steers through the 
chute was not consistent within pens as it was dependent on their arrival at the chute 
system. Feces ( 1 0 - 5 0 g) from each animal was grab sampled daily from all steers 
present in pen 24 and adjacent pen 23. Samples were collected and processed as 
described for the preliminary cattle study. 
Environmental samples were collected and processed from feed bunks and water 
bowls twice each week as previously described for environmental background samples. 
Standing manure samples (10 - 50 g) were collected within 2 h of the morning feeding 
time. Triplicate samples were collected from manure near water bowls, feed troughs and 
between pen fence line in the inoculated and adjacent pens using plastic collection bags. 
Manure patties were chosen to reflect approximately a 24 h stand on the feedlot floor (i.e. 
those showing a dry surface but maintained moisture within the pat). The chute system 
floor was sampled twice each week (one sampling day and one non-sampling day) 
throughout the first inoculation sampling period. The manure samples were enumerated 
for Rm r lactose fermenting CFU as described for the fecal grab samples. 
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3.4.3 Inoculation of Feedlot Cattle with RREC II and RREC III: 
RREC II was isolated from steer 501 in pen 24 after this animal had continuously 
shed Rm r lactose fermenting CFU for a period of 22 days. Following collection, RREC 
II was streaked for purity on TSA and stored in BHI + glycerol broth at -80°C for future 
use. RREC II was believed to be a direct descendant of RREC I, based on lactose 
fermentation, fluorescence on LMX agar and similarity of FAME profiles. RREC II 
cultures were prepared as described previously for RREC I and six of twelve animals in 
pen 17 were inoculated with RREC II. Shedding of Rm r lactose fermenting CFU was 
monitored for all animals in pen 17 and adjacent pen 18 as described previously for 
RREC I including sampling the uninoculated pen 18 prior to sampling the inoculated pen 
17. 
RREC III was isolated in an identical manner as RREC II from steer 421 in pen 
17 after this animal continuously shed Rm r lactose fermenting CFU for a period of 17 
days. This isolate was used in a third inoculation of six of twelve animals in pen 21. 
RREC III cultures, animal inoculations and monitoring of shedding of RmT lactose 
fermenting CFU were performed as described for RREC II and I however both adjacent 
pens 22 and 20 were monitored for transfer of the RREC III isolate. 
3.4.4 Monitoring Transfer to Non-adjacent Pens: 
All yearling steers (n = 360) were weighed and fecal swabs were collected from 
each animal on 3 subsequent dates (5, 11 and 16 weeks post feedlot arrival) following the 
initial inoculation of RREC I - III. Fecal samples were collected and processed as 
previously described above. 
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3.4.5 Collection of Samples from the Chute System: 
Triplicate fecal samples (10 - 50 g) were collected from the chute area using 
plastic collection bags for 6 weeks following the inoculation of animals in pen 24 on two 
separate occasions each week. One collection per week occurred 4-6 h after the steers 
were run through the chute system for grab sampling. The second collection per week 
occurred on a non-sampling day approximately 30 hours after the steers were run through 
the chute system. All samples were processed as previously described for pen floor 
samples. 
3.4.6 Sampling Following Transport to Slaughter: 
With the exception of 5 animals held back for post mortem sampling, steers (n = 
355) were transported 200 km for slaughter in semi-trailers 3 months p.i. of RREC III. 
Five inoculated steers chosen from pen 21 (461, 465, 469) and pen 17 (495, 422) based 
on shedding patterns > 12 d p.i., were housed together at the front of the trailer for the 
transport period. Prior to transport the steers were fecal grab sampled and the feces was 
processed as previously described. Following arrival at the meat packing plant, animals 
were removed from the trailer unit and feces (10 - 50 g) were collected from the trailer 
floor using plastic collection bags. Samples were then transported on ice to the lab and 
processed as previously described for grab samples within 3 h of collection. 
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3.4.7 Post-mortem Tissue and Digesta Samples: 
Steers (5) inoculated with RREC III (460, 464, 476, 468 and 470) were 
slaughtered and intestinal tissue (50-100 g) and digesta (10-50 g) samples were collected 
from 6 regions of the gastrointestinal tract (Figure 3.2) using plastic collection bags. This 
experiment was conducted to determine if the animals' gastrointestinal tracts were still 
colonized by the RREC III cells despite the lack of shedding events for > 30 d. All 5 
steers had shedding episodes for Rm r lactose fermenting CFU during the trial period. 
Four of the steers were directly inoculated and shed for >20 p.i., (460,464, 476 and 468) 
while the fifth animal was an uninoculated pen mate and shed on 6 occasions (470). 
Tissue samples were weighed into 10 g sub-samples, combined with 100 ml of 
sodium phosphate buffer and gently agitated to remove digesta. The samples were 
washed a second time, placed in 90 ml fresh phosphate buffer and homogenized in a 
blender (Model Osterizer, Sunbeam; Ontario, Canada) for 1 min at high speed. The 
homogenate (100 ul) was plated in triplicate on MacConkey + Rm agar and incubated 
overnight at 39°C. 
Digesta samples (10 g wet weight) were combined with 90 ml sodium phosphate 
buffer and stomached for 2 minutes to create a slurry. Samples were then processed, 
plated, incubated and assessed as previously described for fecal samples. One random 
sample from each tissue and digesta region was plated on MacConkey agar to ensure 
rifampicin was the selective criterion. 
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Figure 3.2: The gastrointestinal tract of cattle including A) esophagus, B) rumen, C) 
cecum, D) large intestine, E) reticulum, F) omasum, G) abomasum and H) small 
intestine. Tissue and digesta samples were removed and processed from six areas of the 
large intestinal tract (D) including the cecum (C), colon, rectum and the small intestinal 
tract (H) including the duodenum, jejunum and ileum to determine if the RREC isolates 
continued to colonize the gastrointestinal tract. 
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3.5 Identity of the Rm r Lactose Fermenting Isolates: 
During the course of the three inoculations, 522 Rm r lactose fermenting isolates 
were collected. Fatty acid methyl ester, Biolog and MIC tests were conducted on all or a 
selected subset of the isolates to determine if the Rm r bacteria were direct descendents of 
RREC I. RREC inocula were compared further by 16S rDNA sequence analysis and 
pulsed-field gel electrophoresis. Three E. coli isolates were used as reference strains in 
this study. Escherichia coli A291 (Lethbridge Research Centre culture collection), E. 
coli 0157:H7 4420 (Lethbridge Research Centre culture collection) strains were isolated 
from cattle and characterized previously by Jay Yanke (Curator, Lethbridge Research 
Centre Culture Collection) and E. coli K12 DH5a obtained from Gibco Invitrogen Corp. 
(Burlington, ON). 
3.5.1 Fatty Acid Methyl Ester (FAME) Analysis: 
Lactose fermenting colonies originating from all three inoculations were 
harvested from MacConkey + Rm agar plates, streaked onto TSA and incubated at 39°C 
overnight. Cells were harvested from the TSA and the FAMEs were obtained by 
saponification, methylation, and extraction, as described previously (Eder, 1995; Diogo et 
al, 1999) and as recommended by the MIDI standard protocol (MIDI; Newark, DL). 
The separation of FAMEs was achieved with a Hewlett-Packard (Palo Alto, CA) model 
5890 gas chromatograph equipped with a flame ionization detector and controlled by the 
Sherlock Single Tower Library Generation software (version 1.06; MIDI, Newark, DE). 
Numerical analysis and mean profiles based on the fatty acid patterns of the strains were 
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generated. Euclidean distances of the fatty acids generated by the MIDI software 
package were compared to the initial and subsequent inocula for each positive isolate 
cultured. 
3.5.2 Biolog™ (Carbon Utilization Patterns): 
Rifampicin resistant lactose fermenting isolates were assessed (n = 152/ 478) and 
compared for carbon utilization patterns using the Biolog™ system (Hayward, CA). 
Biolog™ GN2 (Gram negative) panels incorporate 95 different standardized carbon 
sources and 1 control (water). Plates were inoculated with 50 ul saline cell suspension 
(67% transmission) and incubated 37°C for 24 h prior to being read on Biolog™ 
Microstation. Isolate profiles were compared to GN database within the Biolog™ system 
(version 4.01B) and identification was proposed based on carbon utilization patterns. 
3.5.3 Minimum Inhibitory Antibiotic Concentration (MIC) Assessment: 
Biolog™ AST (antibiotic sensitivity testing) panels were used to test and compare 
bacterial sensitivities using 2-fold serial dilutions to varying concentrations of antibiotic 
compounds. The test yielded a minimum inhibitory concentration (MIC) value as well as 
breakpoint interpretations for those antibiotics where standards have been set. Cells were 
grown up and streaked for purity on TSA at 37°C overnight. Single colonies were 
selected and sub-cultured again on TSA at 37°C overnight. Following incubation cell 
suspensions (0.5 McFarland standard) were created in a saline solution (8 ml). An aliquot 
(lOOul) of the cell suspension was transferred to Mueller-Hinton broth and the panels 
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were inoculated. The AST panels were then incubated for 18-24 h and the results read by 
the Biolog Microstation™ Reader and interpreted with the Micronaut™ Merlin program 
that automatically cross-referenced the specific plate schematic and reported the MICs 
and the breakpoint interpretation for each inoculum. 
3.5.4 16S rDNA Sequence Analysis: 
Inoculum isolates RREC I-III were subjected to 16S rDNA sequence analysis 
using a modified protocol from Brumbaugh and co-workers (1988). Cultures were 
incubated at 39°C in a shaking incubator (200 rpm) overnight in TSB. Each culture (2 
ml) was centrifuged at 14,000 rpm for 1 min, the supernatant discarded and the cells were 
re-suspended in 200 ul of a 1 mM EDTA solution. The cell suspension was heated at 
100°C for 5 minutes and stored at -20°C overnight to assist in cell lysis. Cell lysates 
were thawed on ice, centrifuged (14,000 rpm for 1 min) and the cell pellet discarded. 
The resulting DNA solutions were used as templates for the amplification of 16S rDNA 
with FP1 and 1525R primers. Polymerase chain reactions (PCR) were performed with 
QIAGEN Hotstar Taq™ DNA polymerase and Q solution (Mississauga, ON) according 
to the manufacturer's recommended protocol. Reaction mixtures were preheated at 95°C 
for 15 min and subsequently subjected to 45 PCR cycles (94°C for 45 s, 48°C for 30 s 
72°C for 2 min). Template size and purity were examined by agarose gel electrophoresis 
(Sambrook and Russell, 2001). 
Nucleotide sequence analysis was performed on the 16S rDNA PCR products 
prepared from lysed RREC I - III cells by the cycle sequencing method as previously 
described (Lane, 1991). Sequencing reactions were primed with 519R (GWA TTA CCG 
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CGG CKG CTG), FP1 (AGA GTT YGA TYC TGG CT), 1100R (AGG GTT GCG CTC 
GTT G), 338F (ACT CCT ACG GGA GGC AG), 1492R (TAC GGY TAC CTT GTT 
ACG ACT) and 926F (AAA CTY AAA KGA ATT GAC GG). Labeled reactions were 
resolved on a LI-COR Model 4000 automated DNA sequencing system (Lincoln, NE). 
DNA sequence data were assembled with Sequencher version 4.1 (Gene Codes, Ann 
Arbor, MI), aligned with Clustal W version 1.8 software (Thompson et al., 1994) and 
compared with sequences in the GenBank database (Benson et al., 2000) by using the 
BLAST algorithm (Altschul et al., 1990). 
The 16S rDNA sequences for RREC I - III will be deposited in the GenBank 
database. 
3.5. 5 Pulsed-field Gel Electrophoresis (PFGE): 
Pulsed-field gel electrophoresis was performed on the strains from each of the 
inoculations and compared to 3 controls (E. coli A290, 0157:H7 4420 and K12 DH5oc) 
according to a modified protocol previously described by Liu and Sanderson (1995). 
Cultures were grown (15-18 h) on LB agar plates incubated at 37°C overnight. Cell 
suspensions were created in 15 ml Falcon tubes by adding approximately 10 9 cells to 0.5 
ml cell suspension solution (10 mM Tris-HCl [pH 7.2], 20 mM NaCl, lOOmM EDTA) 
and then pre-heated in a water bath at 70°C and mixed with molten 1.4% agarose held at 
70°C. The mixture was then immediately drawn into a tuberculin syringe with the needle 
adapter removed. When the agarose rod had hardened after 20 minutes at room 
temperature, it was sliced into 1 mm thick discs that were placed into lysing buffer 
solution (10 mM Tris-HCl [pH 7.2], 50 mM NaCl, lOOmM EDTA, 0.2% sodium dodecyl 
61 
sulfate, 0.5% TV-laurylsarcosine) and gently shaken at 70°C for 2 h. The discs were then 
drained and washed 2 times (15 min each) in wash solution (20 mM Tris-HCl, [pH 8.0] 
50 mM EDTA) at room temperature and gently agitated. Discs were drained and gently 
agitated with 3 ml of the proteinase K solution (100 mM EDTA, [pH 8.0], 0.2% SDS, 1% 
N-laurylsarcosine sodium salt, 1.0 mg proteinase K /ml buffer solution) at 42°C for 72 h. 
The discs were then washed in wash solution and treated with 3 ml PMSF solution (ImM 
phenyl-methylsulfonyl fluoride in wash solution) and incubated with agitation at room 
temperature for 2 h. Samples were then gently agitated with d2H20 at 37°C for 10 min 
and drained. Plugs were immersed in 40 ul enzyme buffer solution (2X concentration) 
and incubated 10 minutes at room temperature. The buffer solution was then discarded 
and 40 )J.l/plug buffer solution (IX concentration) 0.006 uL/ul total liquid volume of I-
Ceul was added to the plugs and incubated for 2 h at 37°C. A Bio-Rad CHEF-DRII 
apparatus (Bio-Rad; Mississauga, ON) was used to resolve genomic DNA fragments by 
PFGE. Fragment separation was achieved following the l-Ceul digestion with an initial 
switch time of 18 s, final switch time o f 2 0 s a t 5 . 4 volts and a run time of 10 h using 
0.7%) agarose gel. Gels were stained with ethidium bromide and photographed for 
permanent record (Sambrook and Russell, 2001). 
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4. RESULTS: 
4.1 Isolation of RREC I: 
Naturally occurring antibiotic resistant enterococci or enterobacteriaceae were 
screened on antibiotic gradient plates made with BEA agar or MacConkey agar, 
respectively. Nalidixic acid or streptomycin gradient plates prepared with BEA agar 
consistently yielded numerous colonies across each gradient plate. In contrast, no 
colonies grew on BEA agar with gentamicin or rifampicin. Streptomycin gradient plates 
prepared with MacConkey agar were completely covered with bright pink colonies 
(lactose fermenting). No lactose fermenting colonies were observed on the gentamicin or 
nalidixic acid gradient plates made with MacConkey agar. A single isolated colony was 
observed on a MacConkey + Rm gradient plate. The colony grew at an estimated Rm 
concentration of 15 ug/ml. The colony was isolated, streaked for purity, given the strain 
designation RREC I and stored for future use. 
4.2 Characterization of RREC I: 
Preliminary biochemical tests were used to determine the identity of RREC I. 
The isolate produced colonies that fluoresced on LMX agar, were metallic on EMB agar 
and produced tryptophanase when grown in peptone broth. FAME and Biolog™ profiles 
identified RREC I as a member of the genus Escherichia. 
The stability of Rm r for RREC I was tested by multiple passages in TSB. All cells 
were Rm r after greater than 192 generations in TSB. There were no differences observed 
between numbers of colonies cultured on MacConkey + Rm or MacConkey agar. 
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Approximately 1.5 x 10 9 colonies were enumerated each plating and this number 
remained consistent throughout the experiment. 
4.3 Small Scale Cattle Trial: 
Lactose fermenting RREC isolates were not observed either in ruminal or fecal 
samples from the Jersey yearling steers prior to inoculation with the RREC I strain. 
Lactose fermenting RREC were cultured for up to 12 h p.i. in the rumen and were 
detected in the feces after 24 h and persisted for at least 5 days post inoculation (data not 
shown). 
4.4 Feedlot Cattle Study: 
4.4.1 Background Rm r Bacteria: 
Lactose fermenting rifampicin resistant colonies were not cultured from any 
environmental background samples (n = 210) conducted prior to the arrival of the 
yearling steers. Yearling steers (n = 360) were also negative for Rm r isolates. Samples 
from the feedlot and steers produced abundant lactose fermenting colonies when plated 
on MacConkey agar. 
4.4.2 Identification of Rm r Lactose Fermenting Isolates Recovered from Feedlot 
Cattle: 
A total of 522 Rm r isolates were collected during the three cattle inoculations of 
which 501 were lactose fermenting. The MIDI system did not provide a definitive 
identification to the species level for RREC I, or any of isolates recovered from the 
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feedlot cattle. However, when the FAME profiles of 501 recovered Rm r lactose 
fermenting isolates were compared to RREC I-III, 478/501 isolates clustered with RREC 
I - III into 1 major branch differing by < 5 - 10 Euclidean units. Only 23/501 isolates did 
not cluster with RREC I- III. Significant differences were also observed between the 
FAME profiles of the 3 inocula and 3 control strains, E. coli A291 and E. coli 0157:H7 
4420. 
Carbon utilization patterns for a sub-set 152/478 of the Rm r lactose fermenting 
isolates, including RREC II and III, re-isolated during the feedlot trial and RREC I were 
determined with the Biolog™ system. All three inocula (RREC I - III) and the 152 Rm r 
lactose fermenting isolates had identical carbon utilization patterns. Four carbon sources 
(Tween-40, D-glucosaminic acid, D-arabitol and D-saccharic acid) were used by all of 
the Rm r isolates and inocula, but not by typical E. coli according to the Biolog™ 
database. In addition, 11 carbon sources (p-hydroxyphenylacetic acid, bromosuccinic 
acid, a-keto butric acid, oc-keto glutaric acid, alaninamide, D-alanine, gentiobiose, 
propionic acid, D-serine, glucuronic acid and mono-methyl succinate) used by the control 
E. coli A291 strain were not used by the Rm r isolates from this study (Figure 4.1). 
The number of Rm r lactose fermenting isolates collected from various sources 
during the course of the feedlot trial and analyzed for their similarity to RREC by FAME 
and Biolog™ analysis is presented in Table 4.1. Data collected from FAME and 
biochemical profiles and Biolog™ were used to group isolates with the inocula strains. 
Transfer beyond pens 24,23,17, 21 and 22 was not observed. 
The 3 inocula, E. coli A291 and E. coli 0157:H7 4420 were subjected to the 
Biolog™ AST panels to determine levels of antibiotic resistance. MICs were determined 
65 
1 2 3 4 5 6 7 8 9 10 11 12 
AL sextrin Tween 40 Tween 80 
N-acetyl-D-
glactosamine 
N-acetyl-D-
glucosamine L-arabinose D-arabitol cellobiose 
B D-fmctose L-fucose 
D-
galactose 
a-
D-glucose a-lactose 
a-D-lactose 
lactulose maltose D-mannitol D-mannose 
G D-melibiose 
p-methyl D-
glucoside psicose 
D-
raffinose 
L-
rhamnose D-sorbitol sucrose D-trehalose turanose 
methyl 
pyruvate 
D acetic acid 
formic 
acid 
D-glactonic 
acid 
lactone 
D-
galacturonic 
acid 
D-gluconic 
acid 
D-
glucosaminic 
acid 
D-glucuronic 
acid 
E D,L-lactic acid 
D-saccharic 
acid 
F glucuronamide L-alanine 
Lalanyl-
glycine L-asparagine 
L-aspartic 
acid 
glycyl-L-
aspartic acid 
glycyl-L-
glutamic acid 
G L-serine 
H inosine uridine thymidine glycerol 
D,L-a-glycerol 
phosphate 
glucose-1-
phosphate 
Figure 4.1: Carbon utilization pattern of Rm r lactose fermenting isolates collected during the feedlot trial. The table is modified from 
information provided by the manufacturer (Biolog™). 
Table 4.1: Source of isolates collected throughout the feedlot study. All lactose 
fermenting Rm r colonies were subjected to FAME analysis and a select sub-group was 
tested with the Biolog™ system. Isolates are grouped according to source and 
inoculation period. The numerator in the Biolog™ column represents the number of 
isolates similar to RREC and the denominator represents the number of isolates tested by 
the system. 
Total 
# Rm r Isolates # Similar to RREC Collected 
Retrieved from according to Isolates per 
Source Samples Group 
FAME Biolog™ 
Inoculation I 
Pen 24 171 
Animal Samples 148 148 33/33 
Floor Samples 23 23 6/6 
Pen 23 25 
Animal Samples 19 19 Not tested 
Floor Samples 6 6 Not tested 
Inoculation II 
Pen 17 159 
Animal Samples 127 127 68/68 
Floor Samples 32 32 7/7 
Inoculation III 
Pen 21 102 
Animal Samples 102 102 37/37 
Floor Samples n/a 
Chute System 21 
21 21 1/1 
Non-Adjacent 
Pens 23 
Animal Samples 23 0 0/17 
Total: 501 478 152 501 
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for 24 different antibiotics (Table 4.2). All three inocula showed identical MIC patterns 
for all 24 antibiotics tested. Differences between inocula and the E. coli controls were 
observed for 5 antibiotics. The RREC inocula were resistant to cefalothin, cefoxitin and 
ceftiofur and in contrast the E. coli controls were sensitive to these antibiotics. The 3 
RREC inocula were substantially more resistant to rifampicin than the E. coli controls 
(1600 ug/ml vs 4 ug/ml). Finally, intermediate resistance was observed for the 2 control 
strains to tilmicosin whereas RREC I - III were determined to be resistant. 
The 16S rDNA sequences from the inocula (RREC I - III) were aligned with 
Clustal W and found to be nearly identical (>99.7%; Figure 4.2). A consensus sequence 
for the inocula 16S rDNA was compared with entries in the GenBank database and found 
to be > 99.5% homologous (1312-1309/1316 nt) with entries for E. coli, Shigella spp. and 
Klebsiella spp. 
The enzyme I-Ceul was used to cleave genomic DNA from RREC I - III and E. 
coli A291, E. coli K12 DHcc5 and E. coli 0157:H7 4420. Banding patterns generated by 
PFGE showed 7 cleavage sites for all 6 strains with differences in band size observed for 
the controls. The profiles for the inocula were identical to each other but differed 
significantly from the DH5a control strains by the presence of a band 150kb larger 
(Figure 4.3). 
4.4.3 RREC I Inoculation: 
Yearling steers (n = 9/12) from pen 24 were inoculated with approximately 5 x l 0 1 2 
RREC I cells. Rifampicin resistant colonies that appeared similar to RREC I were 
recovered from all inoculated animals and 2 of the uninoculated animals 24 h p.i. (Table 
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Table 4.2: Sensitivity of RREC I - III, E. coli A291 and E. coli 0157:H7 (4420) to 24 
antibiotics. The strains were determined to be sensitive (S), resistant (R) or intermediate 
(I) using the Biolog™ AST panels incorporating 2-fold serial dilutions to varying 
concentrations of each of the listed antibiotic compounds. Differences between inocula 
strains and the E. coli controls were observed for 5 antibiotics ( X ) . 
Differences 
E. coli A291 Between 
Antibiotic RREC i RREC II RREC III 
and 
E. coli 0157 
4420 
RREC and 
Controls 
Amikacin S S S S 
Amoxiciilin/Clavulanic acid S S S S 
Ampicillin s s s S 
Cefalothin R R R S X 
Cefazolin S S S S 
Cefoxitin I I I S X 
Ceftiofur R R R S X 
Chloramphenicol S S S S 
Clindamicin R R R R 
Co-trimoxazole S S S S 
Enrofloxacin S S S S 
Erythromicin R R R R 
Gentamicin S S S S 
Oxacillin R R R R 
Penicillin G R R R R 
Penicillin/Novobiocin R R R R 
Pirlimycin R R R R 
Rifampicin R>1600 R>1600 R>1600 R a t 4 X 
Spectinomycin S S S S 
Sulfadimethoxin R R R R 
Tetracycline S S S S 
Tiamulin R R R R 
Ticarcillin S S S S 
Tilmicosin R R R I X 
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Inocl AACGCTGGCGGCAGCCTAACACATGCAAGTCGAACGGTAACAGAAAGAAGCTTGCTTCTT 60 
InocII CACGCCTAACACATSCAAGTCGAACGGTAACAGAA-GAAGCTTGCTTCTT 49 
I n o d 11 
Inocl TGCTGACGAGTGGCGGACGGGTGAGTAATGTCTGGGAAACTGCCTGATGGAGGGG - ATAA 119 
Inoc 11 - GCTGACGAGTGGCGGACGG- TGAGTAATGTCTGGGAAACTGCCTGATGGAGGGGGATAA 107 
Inocl 11 ACGAGTGGCGGACGGGTGAGTAATGTCTGGGAAACTGCCTGATGGAGGGGGATAA 55 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * **** 
Inocl CTACTGGAAACGGTAGCTAATACCGCATAACGTCGCAAGACCAAAGAGGGGGAC-TTCGG 178 
I noc 11 CTACTGGAAACGGTAGCTAATACCGCATAACGTCGCAAGACCAAAGAGGGGGAC - TTCGG 166 
InocIII CTACTGGAAACGGTAGCTAATACCGCATAACGTCGCAAGACCAAAGAGGGGGACCTTCGG 115 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Inocl GCCTCTTGCCATCGGATGTGCCCAGATGGGATTAGCTTGTTGGTGGGGTAACGGCTCACC 23 8 
InoclI GCCTCTTGCCATCGGATGTGCCCAGATGGGATTAGCTTGTTGGTGGGGTAACGGCTCACC 226 
InocIII GCCTCTTGCCATCGGATGTGCCCAGATGGGATTAGCTTGTTGGTGGGGTAACGGCTCACC 175 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
InocI AAGGCGACGATCCCTAGCTGGTCTGAGAGGATGACCAGCCACACTGGAACTGAGACACGG 298 
Inoc 11 AAGGCGACGATCCCTAGCTGGTCTGAGAGGATGACCAGCCACACTGGAACTGAGACACGG 286 
Inoc III AAGGCGACGATCCCTAGCTGGTCTGAGAGGATGACCAGCCACACTGGAACTGAGACACGG 235 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Inocl TCCAGACTC-TACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGC 357 
InocII TCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGC 346 
InocIII TCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGC 2 95 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
I noc I AGCCATGCCGCGTGTATGAAGAAGGC - TTCGGGTTGTAAAGTACTTTCAGCGGGGAGGAA 416 
InocII AGCCATGCCGCGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGGGGAGGAA 4 06 
Inocl 11 AGCCATGCCGCGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGGGGAGGAA 355 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Inocl GGGAGTAAAGTTAATACCTTTGCTCATTGACGTTACCCGCAGAAGAAGCACCGGCTAACT 4 76 
Inocll GGGAGTAAAGTTAATACCTTTRCTCATTGACGTTACCCGCAGAAGAAGCACCGGCTAACT 466 
Inocl 11 GGGAGTAAAGTTAATACCTTTRCTCATTGACGTTACCCGCAGAAGAAGCACCGGCTAACT 415 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
I noc I CCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTA 536 
I noc 11 CCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTA 526 
I noc 111 CCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTA 4 75 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
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Inocl 
InocII 
InocIII 
AAGCGCACGCAGGCGGTTTGTTAAGTCAGATGTGAAATCCCCGGGCTCAACCTGGGAACT 5 96 
AAGCGCACGCAGGCGGTTTGTTAAGTCAGATGTGAAATCCCCGGGCTCAACCTGGGAACT 586 
AAGCGCACGCAGGCGGTTTGTTAAGTCAGATGTGAAATCCCCGGGCTCAACCTGGGAACT 535 
************************************************************ 
Inocl 
InocII 
InocIII 
GCATCTGATACTGGCAAGCTTGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGT 656 
GCATCTGATACTGGCAAGCTTGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGT 646 
GCATCTGATACTGGCAAGCTTGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGT 5 95 
************************************************************ 
Inocl 
InocII 
InocIII 
GAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACGAAGACTG 716 
GAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACGAAGACTG 706 
GAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACGAAGACTG 655 
************************************************************ 
Inocl 
InocII 
InocIII 
ACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCG 776 
ACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCG 766 
ACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCG 715 
************************************************************ 
Inocl 
InocII 
InocIII 
TAAACGATGTCGACTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTA 83 6 
TAAACGATGTCGACTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTA 826 
TAAACGATGTCGACTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTA 775 
************************************************************ 
Inocl 
InocII 
InocIII 
AGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAAATTGACGGGGGCC 896 
AGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAA- TTGACGGGGGCC 885 
AGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAA- TTGACGGGGGCC 834 
*********************************************** ************ 
Inocl 
InocII 
InocIII 
CGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCT 956 
CGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCT 94 5 
CGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCT 894 
************************************************************ 
Inocl 
InocII 
InocIII 
TGACATCCACAGAACTTTCCAGAGATGGATTGGTGC - TTCGGGAACTGTGAGACAGGTGC 1015 
TGACATCCACAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTGTGAGACAGGTGC 1005 
TGACATCCACAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTGTGAGACAGGTGC 954 
************************************ *********************** 
Inocl 
InocII 
InocIII 
TGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGGGTTAAGTCCCGCAACGAGCGCAA 1075 
TGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGGGTTAAGTCCCGCAACGAGCGCAA 1065 
TGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGGGTTAAGTCCCGCAACGAGCGCAA 1014 
************************************************************ 
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InocI CCCTTATCCTTTGTTGCCAGCGGTCCGGCCGGGAACTCAAAGGAGACTGCCAGTGATAAA 113 5 
Inoc 11 CCCTTATCCTTTGTTGCCAGCGGTCCGGCCGGGAACTCAAAGGAGACTGCCAGTGATAAA 112 5 
InocIII CCCTTATCCTTTGTTGCCAGCGGTCCGGCCGGGAACTCAAAGGAGACTGCCAGTGATAAA 1074 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Inocl CTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGACCAGGGCTACACACG 1195 
InocII CTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGACCAGGGCTACACACG 1185 
InoclII CTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGACCAGGGCTACACACG 1134 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Inocl TGCTACAATGGCGCATACAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCATAAAGT 1255 
I noc 11 TGCTACAATGGCGCATACAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCATAAAGT 1245 
I noc 111 TGCTACAATGGCGCATACAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCATAAAGT 1194 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Inocl GCGTCGTAGTCCGGATTGGAGTCTGCAACTCGACTCC--ATGAAGTCGGAATCGCTAGTA 1313 
InocII GCGTCGTAGTCCGGATTGGAGTCTGCAACTCGATCTCTCATGAAGTCGGAATCGCTAGTA 13 05 
InocIII GCGTCGTAGTCCGGATTGGAGTCTGCAACTCGACTCC- -ATGAAGTCGGAATCGCTAGTA 1252 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Inocl ATCGTGGATCAGAATGCCACGGTGAATACGTTCCCGGGCC-TTGTACACACCGCCCGTCA 1372 
I noc 11 ATCGTGGATCAGAATGCCACGGTGAATACGTTCCCGGGCCCTTGTACACACCGCCCGTCA 1365 
InocIII ATCGTGGATCAGAATGCCACGGTGAATACGTTCCCGGGCC-TTGTACACACCGCCCGTCA 1311 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
InocI CACCATGGGAGTGGGTTGCAAAAGAAGTAGGTAGCTTAACCTTCGGGAGGGCGCTTACCA 143 2 
I noc 11 CACCATGGGAGTGGGTTGCAAAAGAAGTAGGTAGCTTAACCTTCGGGAGGGCGCTTACCA 142 5 
InocIII CACCA 1316 
Inocl CTTTGTGATTCATGACTGGGGTGAAGTCGTAACAAGG 1469 
InocII CTTTGTGATTCATGACTGGGGTGAAGTCGTAACAAGGTAACCGTAGGGGAACCT 1479 
InocIII 
Figure 4.2: CLUSTAL W (1.8) multiple sequence pairwise alignments. Sequence type 
explicitly set to DNA. The sequence format is Pearson. Alignments are set for Inocl 
(RREC I inoculum, 1469 bp), InocII (RREC II inoculum, 1479 bp) and InocIII (RREC III 
inoculum, 1316 bp). Sequence scores are (1:2) 98, (1:3) 99 and (2:3) 99 (Thompson et al., 
1994). 
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Lanes 1 2 3 4 5 6 
Figure 4.3: Separation by PFGE of fragments from l-Ceul digestion of genomic 
DNA from RREC I - III (lanes 1 - 3), E. coli A291 (lane 4), E. coli 0157:H7 
4420 (lane 5) and E. coli K12 DHa5 (lane 6). Arrows (left) mark resolved 
fragments of RREC I - III and (right) E. coli K12 DHa5. Size of fragments (kb) 
were determined by comparison with previously described S. typhimurium l-Ceul 
digestion of genomic DNA (Liu and Sanderson, 1995). 
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4.3). All inoculated animals showed continuous shedding events for a minimum of 9 
days p.i. (506) and maximum 33 days p.i. (501). Sporadic shedding was detected in all 
inoculated animals for at least 22 days p.i. (502) and a maximum of 61 days p.i. (501 and 
504). Uninoculated animals in pen 24 had sporadic shedding events on 2 (413 and 503) 
and 4 (416) occasions. Transfer to pen 23 animals (n = 7/12) was detected and RREC I 
CFU were recovered on several occasions (Table 4.4). No shedding events were detected 
in either pen after 61 days p.i. 
4.4.4 RREC II Inoculation: 
Shedding patterns in steers inoculated with RREC II from steer 501, showed 
similar trends to those observed with RREC I (Table 4.5). All inoculated animals shed 
within 24 h p.i. as did 2 uninoculated animals (411 and 417). Constant shedding occurred 
for a minimum of 9 days p.i. (412) and continued for a maximum of 27 days p.i.(422). 
Sporadic shedding occurred over a 62 d period for animal 422. All uninoculated animals 
began shedding RREC II sporadically within 72 h p.i. and continued to shed RREC II for 
up to 38 days. Animal 411 showed the most consistent shedding pattern (9/10 samples 
over a 15 d period). Transfer of RREC II to the adjacent pen 18 was not observed. 
The RREC I and II were not cultured from either feed or water samples during the 
trial period. However, the strains were recovered from pen floor samples in proportion to 
animals shedding the isolate in that pen (Figure 4.4 and 4.5). The RREC isolates were 
also recovered from the chute system throughout sampling period. 
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Table 4.3: Shedding of RREC I CFU by animals in pen 24 during the time course of the 
first inoculation. Animal ear tag numbers in bold and italicized print identify inoculated 
animals. Shedding patterns were recorded as positive (+) if RREC CFU were detected by 
plating a 10"2 dilution on MacConkey + Rm agar. Non-shedding events are recorded as 
blank. 
Time/Cattle # 413 416 496 498 499 500 501 502 503 504 505 506 
24h + + + + + + + + + + + 
48h + + + + + + + + + + 
72h + + + + + + + + + + 
96 h + + + + + + + + + 
8 Days + + + + + + + + + 
9 Days + + + + + + + + + + + 
10 Days + + + + + + + + 
11 Days + + + + + + + + + 
12 Days + + + + + + + 
15 Days + + + + + 
18 Days + + + + + + 
22 Days + + + + + 
24 Days + + 
26 Days + + + 
29 Days + + 
31 Days + 
33 Days + + + 
36 Days + + 
38 Days + 
40 Days + + + 
43 Days + 
45 Days + + 
47 Days + 
50 Days + + 
52 Days + 
54 Days 
57 Days 
59 Days + 
61 Days + + 
71 Days 
78 Days 
85 Days 
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Table 4.4: Shedding of RREC I CFU in pen 23 following the first inoculation of 9 
yearling steers in the adjacent pen 24. All animals were uninoculated and are identified 
by ear tag numbers. Shedding patterns were recorded as positive (+) if RREC I CFU 
were detected by plating a 10"2 dilution on MacConkey + Rm agar. Non-shedding events 
are recorded as blank. 
Time/Cattle # 483 484 485 486 487 488 489 490 491 492 493 494 
72h 
8 Days + + + 
15 Days 
18 Days 
22 Days 
24 Days 
26 Days + 
29 Days 
31 Days + 
33 Days + + 
36 Days + 
38 Days + 
40 Days + + + + 
43 Days + 
45 Days + + 
47 Days 
50 Days 
52 Days + 
54 Days 
57 Days 
59 Days 
61 Days 
71 Days 
78 Days 
85 Days 
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Table 4.5: Shedding of RREC II CFU by animals in pen 17 during the time course of the 
second inoculation. Animal ear tag numbers in bold and italicized print identify 
inoculated animals. Shedding patterns were recorded as positive (+) if RREC CFU were 
detected by plating a 10"2 dilution on MacConkey + Rm agar. Non-shedding events are 
recorded as blank. 
Time/Cattle # 411 412 414 415 417 418 419 420 421 422 495 497 
24h + + + + + + + + 
48h + + + + + + + + + + + 
72h + + + + + + + + + + + 
6Days + + + + + + + + + + 
7Days + + + + + + + + + + 
8 Days + + + + + + + + + + 
9 Days + + + + + + + + + + 
10 Days + + + + + + + 
13 Days + + + + + + + 
15 Days + + + + + + + 
17 Days + + + + + + 
20 Days + + + + 
22 Days + + 
24 Days + + + 
27 Days + 
29 Days 
31 Days 
36 Days + + 
38 Days + + + 
41 Days 
43 Days + + 
45 Days + 
48 Days 
50 Days + 
53 Days 
56 Days 
57 Days 
59 Days *n/a 
62 Days + 
69 Days 
76 Days 
Data not available (n/a). 
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Figure 4.4: Relationship between the number of RREC positive samples ( A ) from the 
floor of pen 24 and the number of cattle shedding RREC positive samples (•) during a 60 
d period after steers (n = 9/12) were inoculated with RREC I. The trend lines are 
indicated for each data set shown. 
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Figure 4.5: Relationship between the number of RREC positive samples (±) from the 
floor of pen 17 and the number of cattle shedding RREC positive samples (•) during a 
35 d period after steers (n = 6/12) were inoculated with RREC II. The trend lines are 
indicated for each data set shown. 
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4.4.5 RREC III Inoculation: 
Yearling steers (n = 6/12) from pen 21 were inoculated with RREC III isolated 
from animal 421 as previously described. Shedding patterns were similar to those 
observed during the 1 s t and 2 n d inoculations (Table 4.6). All inoculated and uninoculated 
animals shed within 24 h post-inoculation. The duration of continuous shedding was 
longer than observed during the previous 2 trials. Constant shedding in inoculated 
animals occurred for a minimum of 4 days p.i. (469) and for a maximum 30 days p.i. 
(467). Sporadic shedding occurred over a 54 d period animal 464. All uninoculated 
animals shed sporadically within 72 h of p.i. 
4.4.6 Transport and Post-Mortem Samples: 
Rifampicin resistant lactose fermenting isolates were not recovered from either 
the compartment floor of the transport trailer or the post-mortem tissue and digesta 
samples collected from 5 yearling steers immediately following slaughter. Sample 
dilutions spread on MacConkey agar yielded numerous lactose fermenting colonies. 
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Table 4.6: Shedding of RREC III CFU by animals in pen 21 during the time course of 
the third inoculation. Animal ear tag numbers in bold and italicized print identify 
inoculated animals. Shedding patterns were recorded as positive (+) if RREC III CFU 
were detected by plating a 10"2 dilution on MacConkey + Rm agar. Non-shedding events 
are recorded as blank. 
Time/Cattle # 459 460 461 462 463 464 465 466 467 468 469 470 
24h + + + + + + + + + + + + 
48h + + + + + + + + + + + 
72h + + + + + + + + 
96 h + + + + + + + + 
8 Days + + + + + 
9 Days + + + + + + 
10 Days + + + + + + + 
11 Days + + + + + + + 
12 Days + + + + + + 
15 Days + + + + + + 
17 Days + + + + + 
20 Days + + + + + 
23 Days + + + + 
24 Days + + + + + 
26 Days + + + 
29 Days + + + + + 
30 Days + + + 
32 Days + + + 
36 Days + + + + 
38 Days + 
40 Days + + + 
43 Days + 
44 Days 
46 Days 
50 Days + 
52 Days + 
54 Days + 
57 Days 
59 Days 
61 Days 
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5. DISCUSSION: 
In this study we tested the hypothesis that transfer of antibiotic resistant bacteria 
would occur between cattle within and between pens. Although previous studies have 
shown that Salmonella spp. readily move throughout a livestock environment (Holmberg, 
1984b; Molbak et al, 1999), or MRSA through a clinical environment (Levy 1992; 
Roman et al, 1997), transfer of RREC in our study was restricted primarily to the pen 
into which it was introduced. Furthermore, we found transfer of the strain may not be as 
promiscuous as previous studies and reviews have suggested (Barrow et al, 1984; Fisher, 
1994; Bergogne-Berezin 1997; Gustafson and Bowen, 1997; Helmuth and Protz, 1997; 
Khachatourians, 1998; Davies et al, 1999; Klare et al, 1999; Wegener et al, 1999). 
Within 24 h p.i., all inoculated animals (inoculations 1-3) shed the RREC inoculum 
strain. Within 48 h p.i., uninoculated animals within the inoculated pens (24, 17 and 21) 
also shed the strain. The RREC inocula were shed more prolifically and persisted longer 
in inoculated animals than uninoculated animals during all three trials. The magnitude 
and duration of colonization by RREC I - III were similar to those obtained in other cattle 
studies involving E. coli 0157:H7 (Brown et al, 1997; Cray et al, 1998). During these 
E.coli 0157 studies, persistence of the inoculated strain was reported in cattle given 
approximately the same dose (~10 1 2 CFU) as used in our trials. We found no differences 
in colonization or transfer between animals regardless of any preconditioning of the 
inoculum (i.e., RREC II and III were isolated from a shedding animal in trial I and II, 
respectively). We expected RREC II and III to establish more readily in the GI tract of 
the inoculated steers. It has been observed in other studies that laboratory culturing 
reduces the resilience of bacteria cultures (Williams et al, 1996). RREC II was believed 
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to be a direct descendent of the previous RREC I inoculum strain and therefore had re-
colonized in the cattle following culture in the laboratory. Laboratory culturing was 
limited between isolation and re-inoculation with the RREC II. The RREC III inoculum 
was cultured under identical conditions but this time from an RREC II inoculated animal. 
Similarly, increased resilience was not observed and shedding patterns nearly mimicked 
the first and second inoculation experiments. Warmer climate conditions (data not 
shown) may have contributed to the slightly longer shedding pattern of animals during 
the 3 r d inoculation experiment due to persistence of the strain in feces on the pen floor. 
Animals arrived at the experimental facility one week prior to the first inoculation 
with RREC I. Transportation to a new environment along with new animals relationships 
may have contributed to heightened animal stress. Hormones associated with increased 
stress can change micro environments within the animal gut (Blecha, 1988; Hinton et al, 
199'4; Grandin, 1997). Increased prevalence of antibiotic resistant strains of E. coli has 
been recorded in calves following transport (Hinton and Linton, 1983; Hinton et al, 
1984). This change was associated with the displacement of sensitive strains that may 
have been compromised due to subtle changes in the animal digestive tract environment. 
Several studies have been conducted regarding stress and immunity of animals (Blecha, 
1988; Corrier et al, 1990; Hinton et al, 1994). Differences in bacterial competitive 
exclusion in compromised animals may have allowed RREC I to better colonize the guts 
of animals in pens 23 and 24. Differences in stress response by individual animals may 
explain differences observed for shedding events of each animal (Moberg, 1987; Cornick 
et al, 2000). Transfer between pens was only seen during the first inoculation (e.g., 
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between inoculated animals in pen 24 and uninoculated animals in pen 23). Differences 
in animal health or stress may have contributed to transfer between these two pens. 
The RREC inocula did not persist in the GI tract of the cattle beyond the 4 month 
trial period. Transport has been associated with increased antibiotic resistant bacterial 
shedding in calves (Hinton et al, 1994). Following transport, we did not observe 
shedding of the RREC strain and in fact found no traces of the inocula in either post­
mortem GI tissue or digesta samples. These results suggest that the RREC isolates were 
cleared from the digestive tract rather than simply not found as a result of intermittent 
shedding. 
The RREC origin of recovered Rm r lactose fermenting isolates was grouped by 
FAME and carbon source analysis (Table 4.1). The results of these tests suggest that 
95% isolates tested were descendents of the original RREC I isolate. The RREC I, II and 
III were observed to be identical using FAME, Biolog™, MIC, ribotyping (16S rDNA) 
and PFGE and differed from the three E. coli control strains (E. coli A291, E. coli 
0157:H7 4420 and E. coli K12 DHot5). Fatty acid methyl ester (FAME) derivatives 
have been examined as a means of characterizing single species derivatives (Livesley et 
al, 1993). Despite some variations, the isolated strains were found to have very stable 
fatty acid profiles. Results can vary depending on the strain in question and the exact 
growth conditions (Brown et al, 1997). 
The endonuclease l-Ceul, encoded by a class I mobile intron inserted in the gene 
for 23S rRNA in Chlamydomonas eugamatos, cleaves a specific 19-bp sequence in the 
rrn gene and results in large DNA fragments that can be mapped with PFGE. This 
sequence is present only in seven genes for rRNA in S. typhimurium and E. coli (Liu and 
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Sanderson, 1995; Liu et al, 1999). Because of conservation of l-Ceul sites in genes for 
rRNA and conservation of the number and locations of the rrn gene, l-Ceul provides an 
excellent tool for the rapid examination of the chromosomes of related species of 
bacteria. The l-Ceul digestion of genomic DNA resulted in 7 bands for all six digestions 
indicating all strains were closely related. RREC I, II and III resulted in indistinguishable 
PFGE patterns suggesting the 3 inocula isolates were representative of the same strain 
(Tenover et al, 1995). Each succeeding inoculum was isolated from an animal shedding 
the previous RREC inoculum (e.g. RREC II came from a steer inoculated with RREC I) 
beyond the normal transition period of a ruminant (>5 d; Brown et al, 1997; Cheeke, 
1999). For this reason, it was determined that the RREC inocula had persisted in the 
steers' digestive system. 
During the design phase of this experiment it was determined that an innate 
antibiotic resistant bacterium should be chosen for uniqueness and ease of selection 
throughout the trial period. Isolates grown on BEA agar produced slower growing and 
smaller colonies requiring more incubation time (24 h) than the lactose fermenting RREC 
isolate chosen from MacConkey agar. The RREC I isolate was recovered from an animal 
that had never been exposed to rifampicin using an antibiotic gradient plate. Rifampicin 
resistance is coded chromosomally and consequently more likely to be maintained in the 
absence of antibiotic selective pressure (Ingham and Fumeaux; 2000). Rifampicin binds 
to the B-subunit of RNA polymerase, inhibiting DNA transcription. By modifying the 
target enzyme without disrupting its function the bacterium is able to continue with DNA 
transcription and counteract the inhibiting effects of rifampicin. Rifampicin resistance is 
expressed as an altered target enzyme through numerous insertions, deletions or amino 
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acid substitutions within the target enzyme (Fukuda and Nagasawa-Fujimori, 1983). 
Most of the seventeen reported alterations occur within a highly conserved region (507 to 
534) of the B-subunit of RNA polymerase (Spratt, 1994; Ingham and Furneaux; 2000). 
Throughout this experiment, the cattle were not fed antibiotics and thus the colonization 
and persistence of RREC cells occurred in the absence of obvious selection. The RREC I 
isolate remained resistant to Rm > 192 generations during the laboratory experiment 
without the addition of Rm to the culture media. 
E. coli is among the most prevalent microorganisms in cattle feces making up 
- 3 % of the micro-flora population (Hrubant et al, 1972; Carroll and Jasper, 1978; Perotti 
et al, 2001). Selective media such as MacConkey + Rm and LMX (Manafi et al, 1991) 
allowed reasonable confidence in selecting a RREC isolate. MacConkey agar controls 
were incorporated into each experiment involving the re-isolation of RREC I through III 
cells, to ensure that rifampicin plates were selective due to the inclusion of the antibiotic 
and not because of medium composition. 
Environmental samples were cultured throughout the first and second inoculation 
experiments in an attempt to determine the mode of isolate transfer between inoculated 
and uninoculated animals. RREC I cells (or CFU) were not recovered from water bowls 
or feed bunks. Yearling steers shed inoculated strains within 24 h and as did most 
uninoculated animals. The short duration to infection and the lack of RREC CFU found 
in environmental samples supporting fecal-oral transmission rather than fecal-feed-oral or 
fecal-water-oral mode of transmission. Uninoculated cattle were most likely infected 
with a large number of transient RREC I cells excreted in feces by the inoculated cattle or 
through animal-to-animal contact (Clinton et al, 1981). The number of isolates 
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recovered from pen floor samples was indicative of the number of animals shedding 
RREC in that pen (Figure 4.4 and 4.5). Positive samples were cultured from feces lying 
at the fence line between two pens suggesting that the transfer between animals in pens 
24 and 23 may have occurred due to fecal contamination. Inoculated pen animals were 
put through the chute system prior to animals from adjacent pens during each sampling 
event. The RREC isolates were recovered from the chute system floor on non-sampling 
days suggesting that the chute system may also be a source of bacteria transfer between 
animals. During regular handling and processing of cattle in a commercial feedlot 
system, the chute is a common point to which all cattle are exposed. Cleaning of the 
chute system periodically during and immediately following use, may reduce transfer not 
only of antibiotic resistant bacteria but also disease causing bacteria among cattle in the 
feedlot. 
During a study conducted by Marshall and co-workers (1990), E. coli isolates of 
bovine or porcine gut origin spread readily into human and other animal host species 
including chickens, flies and mice that were in direct contact with each other. During this 
study it was also observed that minimizing contact between animal hosts (separation into 
pens) minimized bacterial exchange and in fact transfer was only observed between 
animals with direct contact. Marshall and coworkers (1990) hypothesized that 
colonization may have persisted because of re-ingestion from environmental sources 
despite low environmental density of the test organism. They also suggested that factors 
other than environmental density, such as bacterial competitive exclusion, animal feed 
differences or health, enhanced the intraspecies transfer. 
87 
Transfer of antibiotic resistant Salmonella spp. (Holmberg et al, 1984a; Davies et 
al, 1999; Molbak et al, 1999) and MRSA (Roman et al, 1997) has been observed in 
human clinical studies. Although great care is taken with respect to sterility and aseptic 
technique, it is inevitable that transfer of these pathogenic bacteria occurs between 
patients. Patients in the clinical environment are likely to be immune compromised and 
thus more susceptible to colonization of a novel strain in their systems. In addition, 
antibiotic selective pressure exists within the institution as physicians regularly prescribe 
antibiotics for hospitalized patients (Lipsitch et al, 2000). Although sterility did not exist 
in the feedlot environment, animal-to-animal contact was minimized between pens and 
antibiotics were not used during the trial period. This may explain the reduced transfer 
observed in this experiment. 
Characterization of RREC II and RREC III confirmed that colonization of cattle 
lower GI tract occurred during this experiment on 3 separate occasions with 3 separate 
sets of animals in the absence of antibiotic selection. Transfer between animals also 
occurred within the inoculated pens (pen 24,17 and 21). Transfer between pens did not 
occur beyond the first inoculation despite our attempts to increase the persistence of 
RREC I by passing it through an animal host. Animals did not shed the RREC strains 
beyond a 62 d period. Post-mortem experiments did not observe colonization in the 
gastrointestinal tract 30 days after the last shedding event of any animal in the inoculated 
pen. 
Innate antibiotic resistance exists in cattle populations regardless of antibiotic 
use. The RREC I inoculum was isolated from an animal that had never received 
rifampicin. Antibiotics including rifampicin were never administered to any animal 
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involved in this experiment. On 17 occasions during this experiment, lactose fermenting 
Rm r isolates that were determined not to be descendents of the RREC inocula were 
cultured. 
We are well aware that antibiotic use patterns are important in the development of 
bacterial resistance. Antibiotic dosage and time of administration would be expected to 
have an effect on the frequency that resistant strains are selected in a particular setting 
(Lipsitch and Levin, 1997). This study supports the hypothesis that risk can be decreased 
for the transfer of antibiotic resistant bacterial strains under non-selective conditions. In 
the absence of selective pressure, colonization of the digestive tract of the feedlot cattle 
may be a short duration process and rampant movement of an antibiotic resistant bacteria 
throughout the feedlot environment is not the norm. Further study is needed to determine 
the effects of antibiotic treatment and stress on the transfer of antibiotic resistant bacteria 
in feedlot cattle. 
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